Stefan Agewall

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2024;10(1):3-4

Anticoagulation in cancer-associated thrombosis: how long should the therapy be?

Xiong W; Agewall S; Yamashita Y
Journal article: EUROPEAN HEART JOURNAL. 2023;44(42):4485-4487

Concerns about aortic aneurysm or dissection risk should not cease fluoroquinolone use when clinically indicated.

Tamargo J; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(7):593-594

Antiplatelet treatment after PCI.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(6):570-582

Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?

Drexel H; Tamargo J; Kaski JC; Lewis BS; Saely CH; Fraunberger P; Dobrev D; Komiyama M; Plattner T; Agewall S; Hasegawa K
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(6):497-498

Cardiovascular preventive actions.

Agewall S
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(18):14143

Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease.

Wärme J; Sundqvist MO; Hjort M; Agewall S; Collste O; Ekenbäck C; Frick M; Henareh L; Hofman-Bang C; Spaak J; Sörensson P; Y-Hassan S; Svensson P; Lindahl B; Hofmann R; Tornvall P
Article: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2023;9(6):639-644

Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries.

Berg E; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Ekenbäck C; Jensen J; Y-Hassan S; Henareh L; Maret E; Spaak J; Sörensson P; Tornvall P; Lyngå P
Journal article: EUROPEAN HEART JOURNAL OPEN. 2023;3(5):oead089

Intima-media thickness at the near or far wall of the common carotid artery in cardiovascular risk assessment.

Seekircher L; Tschiderer L; Lind L; Safarova MS; Kavousi M; Ikram MA; Lonn E; Yusuf S; Grobbee DE; Kastelein JJP; Visseren FLJ; Walters M; Dawson J; Higgins P; Agewall S; Catapano A; de Groot E; Espeland MA; Klingenschmid G; Magliano D; Olsen MH; Preiss D; Sander D; Skilton M; Zozulińska-Ziółkiewicz DA; Grooteman MPC; Blankestijn PJ; Kitagawa K; Okazaki S; Manzi MV; Mancusi C; Izzo R; Desvarieux M; Rundek T; Gerstein HC; Bots ML; Sweeting MJ; Lorenz MW; Willeit P
Journal article: CLINICAL RESEARCH IN CARDIOLOGY. 2023;:1-9

Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus.

Fröhlich H; Bossmeyer A; Kazmi S; Goode KM; Agewall S; Atar D; Grundtvig M; Frey N; Cleland JGF; Frankenstein L; Clark AL; Täger T
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(5):401-402

Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?
Journal article: JOURNAL OF REHABILITATION MEDICINE. 2023;55:4569-jrm4569

Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction.

Tjessum L; Agewall S
Journal article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2023;12(12):e027657

Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies.

Tschiderer L; Seekircher L; Izzo R; Mancusi C; Manzi MV; Baldassarre D; Amato M; Tremoli E; Veglia F; Tuomainen T-P; Kauhanen J; Voutilainen A; Iglseder B; Lind L; Rundek T; Desvarieux M; Kato A; de Groot E; Aşçi G; Ok E; Agewall S; Beulens JWJ; Byrne CD; Calder PC; Gerstein HC; Gresele P; Klingenschmid G; Nagai M; Olsen MH; Parraga G; Safarova MS; Sattar N; Skilton M; Stehouwer CDA; Uthoff H; van Agtmael MA; van der Heijden AA; Zozulińska-Ziółkiewicz DA; Park H-W; Lee M-S; Bae J-H; Beloqui O; Landecho MF; Plichart M; Ducimetiere P; Empana JP; Bokemark L; Bergström G; Schmidt C; Castelnuovo S; Calabresi L; Norata GD; Grigore L; Catapano A; Zhao D; Wang M; Liu J; Ikram MA; Kavousi M; Bots ML; Sweeting MJ; Lorenz MW; Willeit P; Proof‐ATHERO Study Group
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;:pvad037-296

Focus on prevention in diabetes mellitus and lipid disorder.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(4):353-370

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022.

Tamargo J; Agewall S; Borghi C; Ceconi C; Cerbai E; Dan GA; Ferdinandy P; Grove EL; Rocca B; Sulzgruber P; Semb AG; Sossalla S; Niessner A; Kaski JC; Dobrev D
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(3):199-200

A tailor-made suit always fits best.

Agewall S
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023;81(11):1130-1132

RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action.

Schneider A; Atar D; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(2):119-120

Focus on lipid treatment.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2023;9(2):121

Fibrates: one more lost paradise in lipid treatment.

Drexel H; Saely CH; Agewall S
Journal article: BIOMEDICINE & PHARMACOTHERAPY. 2023;158:114064

Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

Martínez-Montesinos L; Rivera-Caravaca JM; Agewall S; Soler E; Lip GYH; Marín F; Roldán V
Journal article: PLOS ONE. 2023;18(2):e0281155

High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis.

Nguyen THP; Fagerland MW; Hollan I; Whist JE; Feinberg MW; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;9(1):1-3

Pharmacological treatment of CVD.

Agewall S
Journal article: JOURNAL OF CLINICAL MEDICINE. 2022;11(24):7330

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies.

Hokstad I; Greco D; Deyab G; Fagerland MW; Agewall S; Hjeltnes G; Zimetti F; Bernini F; Ronda N; Hollan I
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(8):754-755

To treat or not to treat.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(8):753

Future of European Heart Journal Cardiovascular Pharmacotherapy.

Agewall S
Journal article: EUROPEAN HEART JOURNAL. 2022;43(45):4719-4721

Toward personalized medicine for cardiovascular pharmacotherapy.

Tamargo J; Hasegawa K; Agewall S
Journal article: EUROPEAN HEART JOURNAL. 2022;43(37):3512-3527

Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.

De Caterina R; Agewall S; Andreotti F; Angiolillo DJ; Bhatt DL; Byrne RA; Collet J-P; Eikelboom J; Fanaroff AC; Gibson CM; Goette A; Hindricks G; Lip GYH; Potpara T; Thiele H; Lopes RD; Galli M
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(7):645-647

Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(7):738-751

Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events.

Tamargo J; Kaski JC; Kimura T; Barton JC; Yamamoto K; Komiyama M; Drexel H; Lewis BS; Agewall S; Hasegawa K
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(6):537-538

Prevention is still the key to success.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(5):431-433

Focus on optimizing treatment of coronary heart disease.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(5):e25

Future of antithrombotic therapy for heart failure with coronary artery disease.

Komiyama M; Agewall S; Hasegawa K
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(4):323-324

Focus on different aspects of atrial fibrillation.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(3):213-215

New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials.

Agewall S
Journal article: CLINICAL RESEARCH IN CARDIOLOGY. 2022;111(4):428-439

Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis.

Täger T; Frankenstein L; Atar D; Agewall S; Frey N; Grundtvig M; Clark AL; Cleland JGF; Fröhlich H
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(3):327-337

Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries.

Svenungsson E; Spaak J; Strandberg K; Wallén HN; Agewall S; Brolin EB; Collste O; Daniel M; Ekenbäck C; Frick M; Henareh L; Malmqvist K; Elvin K; Sörensson P; Y-Hassan S; Hofman-Bang C; Tornvall P
Journal article: JOURNAL OF WOMENS HEALTH. 2022;31(3):310-320

The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction.

Hall TS; Ørn S; Zannad F; Rossignol P; Duarte K; Solomon SD; Atar D; Agewall S; Dickstein K; Girerd N
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(2):105-107

Optimizing individual heart failure treatment.

Agewall S
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(1):100-103

Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Magavern EF; Kaski JC; Turner RM; Drexel H; Janmohamed A; Scourfield A; Burrage D; Floyd CN; Adeyeye E; Tamargo J; Lewis BS; Kjeldsen KP; Niessner A; Wassmann S; Sulzgruber P; Borry P; Agewall S; Semb AG; Savarese G; Pirmohamed M; Caulfield MJ
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(1):1-3

Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient.

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(6):461-462

Unsolved pharmacological issues with cardiology.

Agewall S
Article: CLINICAL CARDIOLOGY. 2021;44(11):1567-1574

Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study.

Y-Hassan S; Sörensson P; Ekenbäck C; Lundin M; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Jensen J; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Winnberg O; Ugander M; Tornvall P; Henareh L
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(5):361-362

More knowledge about atrial fibrillation, still we need to learn.

Agewall S
Article: JACC-CARDIOVASCULAR IMAGING. 2021;14(9):1774-1783

Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

Sörensson P; Ekenbäck C; Lundin M; Agewall S; Bacsovics Brolin E; Caidahl K; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Winnberg O; Ugander M; Tornvall P
Journal article: EUROPEAN HEART JOURNAL. 2021;42(30):2909-2911

Fluoroquinolone use and valvular heart disease: is the jury still out?

Tamargo J; Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(4):261-262

Adherence to pharmacological treatment: how can we improve?

Agewall S
Journal article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(3):169-170

Different aspects of giving the optimal antiplatelet treatment.

Agewall S
Article: AMERICAN HEART JOURNAL. 2021;231:96-104

Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.

Nordenskjöld AM; Agewall S; Atar D; Baron T; Beltrame J; Bergström O; Erlinge D; Gale CP; López-Pais J; Jernberg T; Johansson P; Ravn-Fisher A; Reynolds HR; Somaratne JB; Tornvall P; Lindahl B
Journal article: PLOS ONE. 2021;16(7):e0253247

Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.

Deyab G; Reine TM; Vuong TT; Jenssen T; Hjeltnes G; Agewall S; Mikkelsen K; Førre Ø; Fagerland MW; Kolset SO; Hollan I
Journal article: EUROPEAN HEART JOURNAL. 2020;41:1640

The association of smoking to cardiovascular death differs according to age and sex following myocardial infarction complicated by heart failure or left ventricular dysfunction

Hall TS; Orn S; Zannad F; Rossignol P; Duarte K; Solomon S; Atar D; Agewall S; Dickstein K; Girerd N
Article: CIRCULATION. 2020;142(7):621-642

Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.

Willeit P; Tschiderer L; Allara E; Reuber K; Seekircher L; Gao L; Liao X; Lonn E; Gerstein HC; Yusuf S; Brouwers FP; Asselbergs FW; van Gilst W; Anderssen SA; Grobbee DE; Kastelein JJP; Visseren FLJ; Ntaios G; Hatzitolios AI; Savopoulos C; Nieuwkerk PT; Stroes E; Walters M; Higgins P; Dawson J; Gresele P; Guglielmini G; Migliacci R; Ezhov M; Safarova M; Balakhonova T; Sato E; Amaha M; Nakamura T; Kapellas K; Jamieson LM; Skilton M; Blumenthal JA; Hinderliter A; Sherwood A; Smith PJ; van Agtmael MA; Reiss P; van Vonderen MGA; Kiechl S; Klingenschmid G; Sitzer M; Stehouwer CDA; Uthoff H; Zou Z-Y; Cunha AR; Neves MF; Witham MD; Park H-W; Lee M-S; Bae J-H; Bernal E; Wachtell K; Kjeldsen SE; Olsen MH; Preiss D; Sattar N; Beishuizen E; Huisman MV; Espeland MA; Schmidt C; Agewall S; Ok E; Aşçi G; de Groot E; Grooteman MPC; Blankestijn PJ; Bots ML; Sweeting MJ; Thompson SG; Lorenz MW; PROG-IMT and the Proof-ATHERO Study Groups
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2020;73(6):495.e1-495.e61

2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes

Knuuti J; Wijns W; Saraste A; Capodanno D; Barbato E; Funck-Brentano C; Prescott E; Storey RF; Deaton C; Cuisset T; Agewall S; Dickstein K; Edvardsen T; Escaned J; Gersh BJ; Svitil P; Gilard M; Hasdai D; Hatala R; Mahfoud F; Masip J; Muneretto C; Valgimigli M; Achenbach S; Bax JJ
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2020;27(3):234-243

Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium.

Bahls M; Lorenz MW; Dörr M; Gao L; Kitagawa K; Tuomainen T-P; Agewall S; Berenson G; Catapano AL; Norata GD; Bots ML; van Gilst W; Asselbergs FW; Brouwers FP; Uthoff H; Sander D; Poppert H; Hecht Olsen M; Empana JP; Schminke U; Baldassarre D; Veglia F; Franco OH; Kavousi M; de Groot E; Mathiesen EB; Grigore L; Polak JF; Rundek T; Stehouwer CDA; Skilton MR; Hatzitolios AI; Savopoulos C; Ntaios G; Plichart M; McLachlan S; Lind L; Willeit P; Steinmetz H; Desvarieux M; Ikram MA; Johnsen SH; Schmidt C; Willeit J; Ducimetiere P; Price JF; Bergström G; Kauhanen J; Kiechl S; Sitzer M; Bickel H; Sacco RL; Hofman A; Völzke H; Thompson SG; PROG-IMT Study Group
Article: EUROPEAN HEART JOURNAL. 2020;41(4):543-603

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Konstantinides SV; Meyer G; Becattini C; Bueno H; Geersing G-J; Harjola V-P; Huisman MV; Humbert M; Jennings CS; Jiménez D; Kucher N; Lang IM; Lankeit M; Lorusso R; Mazzolai L; Meneveau N; Ní Áinle F; Prandoni P; Pruszczyk P; Righini M; Torbicki A; Van Belle E; Zamorano JL; ESC Scientific Document Group
Article: GERONTOLOGY. 2020;66(5):447-459

The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale.

Tschiderer L; Seekircher L; Klingenschmid G; Izzo R; Baldassarre D; Iglseder B; Calabresi L; Liu J; Price JF; Bae J-H; Brouwers FP; de Groot E; Schmidt C; Bergström G; Aşçi G; Gresele P; Okazaki S; Kapellas K; Landecho MF; Sattar N; Agewall S; Zou Z-Y; Byrne CD; Nanayakkara PWB; Papagianni A; Witham MD; Bernal E; Ekart R; van Agtmael MA; Neves MF; Sato E; Ezhov M; Walters M; Olsen MH; Stolić R; Zozulińska-Ziółkiewicz DA; Hanefeld M; Staub D; Nagai M; Nieuwkerk PT; Huisman MV; Kato A; Honda H; Parraga G; Magliano D; Gabriel R; Rundek T; Espeland MA; Kiechl S; Willeit J; Lind L; Empana JP; Lonn E; Tuomainen T-P; Catapano A; Chien K-L; Sander D; Kavousi M; Beulens JWJ; Bots ML; Sweeting MJ; Lorenz MW; Willeit P; Proof-ATHERO Study Group
Article: AMERICAN JOURNAL OF THERAPEUTICS. 2019;26(6):e671-e678

All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System.

von Lueder TG; Atar D; Agewall S; Jensen JK; Hopper I; Kotecha D; Mentz RJ; Kim MH; Serebruany VL
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(4):210-215

Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System.

Serebruany VL; Hall TS; Atar D; Agewall S; Hyun Kim M; Geudelin B; Lomakin N; Marciniak TA
Article: AMERICAN HEART JOURNAL. 2019;215:83-90

Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction.

Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Solomon SD; Dickstein K; Atar D; Agewall S; Girerd N; High-Risk Myocardial Infarction Database Initiativ
Article: EUROPEAN RESPIRATORY JOURNAL. 2019;54(3):1901647

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Konstantinides SV; Meyer G; Becattini C; Bueno H; Geersing G-J; Harjola V-P; Huisman MV; Humbert M; Jennings CS; Jiménez D; Kucher N; Lang IM; Lankeit M; Lorusso R; Mazzolai L; Meneveau N; Áinle FN; Prandoni P; Pruszczyk P; Righini M; Torbicki A; Van Belle E; Zamorano JL; The Task Force for the diagnosis and management of
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;289:83-90

Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.

Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Article: HEART. 2019;105(16):1252-1259

Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.

Fröhlich H; Rosenfeld N; Täger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
Article: CLINICAL CHEMISTRY. 2019;65(8):1023-1030

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries.

Hjort M; Eggers KM; Lindhagen L; Agewall S; Brolin EB; Collste O; Daniel M; Ekenbäck C; Frick M; Henareh L; Hofman-Bang C; Malmqvist K; Spaak J; Sörensson P; Y-Hassan S; Tornvall P; Lindahl B
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;287:128-131

ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries.

Hausvater A; Pasupathy S; Tornvall P; Gandhi H; Tavella R; Beltrame J; Agewall S; Ekenbäck C; Brolin EB; Hochman JS; Collste O; Reynolds HR
Article: CIRCULATION. 2019;139(18):e891-e908

Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.

Tamis-Holland JE; Jneid H; Reynolds HR; Agewall S; Brilakis ES; Brown TM; Lerman A; Cushman M; Kumbhani DJ; Arslanian-Engoren C; Bolger AF; Beltrame JF; American Heart Association Interventional Cardiova
Article: AMERICAN JOURNAL OF MEDICINE. 2019;132(3):374-381.e1

Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries.

Nero D; Agewall S; Daniel M; Caidahl K; Collste O; Ekenbäck C; Frick M; Henareh L; Jernberg T; Malmqvist K; Schenck-Gustafsson K; Spaak J; Sörensson P; Sundin Ö; Y-Hassan S; Hofman-Bang C; Tornvall P
Article: EUROPEAN HEART JOURNAL. 2019;40(7):572

EHJ Cardiovascular Pharmacotherapy has Impact Factor.

Agewall S
Article: EUROPEAN HEART JOURNAL SUPPLEMENTS. 2019;21(Suppl A):A28-A33

Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate.

Rosano GMC; Spoletini I; Agewall S
Article: EUROPEAN HEART JOURNAL. 2019;40(2):87-165

2018 ESC/EACTS Guidelines on myocardial revascularization.

Neumann F-J; Sousa-Uva M; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Jüni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO; ESC Scientific Document Group
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2019;72(1):151-226

2018 ESC/EACTS Guidelines on myocardial revascularization

Neumann F-J; Sousa-Uva M; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Juni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO; Wijns W; Glineur D; Aboyans V; Achenbach S; Agewall S; Andreotti F; Barbato E; Baumbach A; Brophy J; Bueno H; Calvert PA; Capodanno D; Davierwala PM; Delgado V; Dudek D; Freemantle N; Funck-Brentano C; Gaemperli O; Gielen S; Gilard M; Gorenek B; Haasenritter J; Haude M; Ibanez B; Lung B; Jeppsson A; Katritsis D; Knuuti J; Kolh P; Leite-Moreira A; Lund LH; Maisano F; Mehilli J; Metzler B; Montalescot G; Pagano D; Petronio AS; Piepoli MF; Popescu BA; Sadaba R; Shlyakhto E; Silber S; Simpson LA; Spary D; Tavilla G; Thiele H; Tousek P; Van Belle E; Vranckx P; Witkowski A; Zamorano JL; Roffi M
Article: KARDIOLOGIA POLSKA. 2019;77(2):71-159

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Williams B; Mancia G; Spiering W; Rosei EA; Azizi M; Burnier M; Clement DL; Coca A; de Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen SE; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder RE; Shlyakhto E; Tsioufis C; Aboyans V; Desormais I
Article: PLOS ONE. 2019;14(7):e0220079

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study.

Hokstad I; Deyab G; Wang Fagerland M; Lyberg T; Hjeltnes G; Førre Ø; Agewall S; Mollnes TE; Hollan I
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2019;55(1):4-90

2018 ESC/EACTS Guidelines on myocardial revascularization.

Sousa-Uva M; Neumann F-J; Ahlsson A; Alfonso F; Banning AP; Benedetto U; Byrne RA; Collet J-P; Falk V; Head SJ; Jüni P; Kastrati A; Koller A; Kristensen SD; Niebauer J; Richter DJ; Seferovic PM; Sibbing D; Stefanini GG; Windecker S; Yadav R; Zembala MO; ESC Scientific Document Group
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2018;71(10):837.e1-837.e92

2018 ESC Guidelines for the diagnosis and management of syncope

Brignole M; Moya A; de lange FJ; Deharo J-C; Elliott PM; Fanciulli A; Fedorowski A; Furlan R; Kenny RA; Martin A; Probst V; Reed MJ; Rice CP; Sutton R; Ungar A; van Dijk JG; Torbicki A; Moreno J; Aboyans V; Agewall S; Asteggiano R; Blanc J-J; Bornstein N; Boveda S; Bueno H; Burri H; Coca A; Collet J-P; Costantino G; Diaz-Infante E; Delgado V; Dolmans F; Gaemperli O; Gajek J; Hindricks G; Kautzner J; Knuuti J; Kulakowski P; Lambrinou E; Leclercq C; Mabo P; Morillo CA; Piepoli MF; Roffi M; Shen WK; Simpson IA; Stockburger M; Vanbrabant P; Windecker S; Luis Zamorano J
Article: EUROPEAN HEART JOURNAL. 2018;39(34):3165-3241

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V; Roos-Hesselink JW; Bauersachs J; Blomström-Lundqvist C; Cífková R; De Bonis M; Iung B; Johnson MR; Kintscher U; Kranke P; Lang IM; Morais J; Pieper PG; Presbitero P; Price S; Rosano GMC; Seeland U; Simoncini T; Swan L; Warnes CA; ESC Scientific Document Group
Article: AMERICAN JOURNAL OF MEDICINE. 2018;131(9):1118-1124

Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries.

Daniel M; Agewall S; Berglund F; Caidahl K; Collste O; Ekenbäck C; Frick M; Henareh L; Jernberg T; Malmqvist K; Schenck-Gustafsson K; Spaak J; Sundin Ö; Sörensson P; Y-Hassan S; Hofman-Bang C; Tornvall P
Article: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2018;49:91-97

Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.

Deyab G; Hokstad I; Aaseth J; Småstuen MC; Whist JE; Agewall S; Lyberg T; Tveiten D; Hjeltnes G; Zibara K; Hollan I
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1)

P1814Deaths and vascular outcomes with non-vitamin K oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system

Von Lueder TA; Atar D; Agewall S; Jensen J; Hopper I; Kotecha D; Mentz R; Serebruany VL
Journal article: EUROPEAN HEART JOURNAL. 2018;39(suppl_1)

P6392Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction

Hall TS; Von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(3):180-188

Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Rosano GMC; Tamargo J; Kjeldsen KP; Lainscak M; Agewall S; Anker SD; Ceconi C; Coats AJS; Drexel H; Filippatos G; Kaski JC; Lund L; Niessner A; Ponikowski P; Savarese G; Schmidt TA; Seferovic P; Wassmann S; Walther T; Lewis BS
Article: EUROPEAN HEART JOURNAL. 2018;39(24):2274-2281

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Niessner A; Tamargo J; Koller L; Saely CH; Schmidt TA; Savarese G; Wassmann S; Rosano G; Ceconi C; Torp-Pedersen C; Kaski JC; Kjeldsen KP; Agewall S; Walther T; Drexel H; Lewis BS
Article: EUROPEAN HEART JOURNAL. 2018;39(21):1883-1948

2018 ESC Guidelines for the diagnosis and management of syncope.

Brignole M; Moya A; de Lange FJ; Deharo J-C; Elliott PM; Fanciulli A; Fedorowski A; Furlan R; Kenny RA; Martín A; Probst V; Reed MJ; Rice CP; Sutton R; Ungar A; van Dijk JG; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2018;39(21):e43-e80

Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope.

Brignole M; Moya A; de Lange FJ; Deharo J-C; Elliott PM; Fanciulli A; Fedorowski A; Furlan R; Kenny RA; Martín A; Probst V; Reed MJ; Rice CP; Sutton R; Ungar A; van Dijk JG; ESC Scientific Document Group
Journal article: EUROPEAN HEART JOURNAL. 2018;39(21):1980

2017 ESC/EACTS Guidelines for the management of valvular heart disease (vol 38, pg 2739, 2017)

Baumgartner H; Falk V; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Raphael Rosenhek DRM; Sjogren J; Mas PT; Vahanian A; Walther T; Wendler O; Windecker S; Zamorano JL
Article: EUROPACE. 2018;20(5):731-732an

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).

Dan G-A; Martinez-Rubio A; Agewall S; Boriani G; Borggrefe M; Gaita F; van Gelder I; Gorenek B; Kaski JC; Kjeldsen K; Lip GYH; Merkely B; Okumura K; Piccini JP; Potpara T; Poulsen BK; Saba M; Savelieva I; Tamargo JL; Wolpert C; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(2):82-92

Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study.

Fröhlich H; Henning F; Täger T; Schellberg D; Grundtvig M; Goode K; Corletto A; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Frankenstein L; Clark AL
Article: EUROPEAN HEART JOURNAL. 2018;39(9):763-816

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Aboyans V; Ricco J-B; Bartelink M-LEL; Björck M; Brodmann M; Cohnert T; Collet J-P; Czerny M; De Carlo M; Debus S; Espinola-Klein C; Kahan T; Kownator S; Mazzolai L; Naylor AR; Roffi M; Röther J; Sprynger M; Tendera M; Tepe G; Venermo M; Vlachopoulos C; Desormais I; ESC Scientific Document Group
Article: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2018;55(3):305-368

Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Aboyans V; Ricco J-B; Bartelink M-LEL; Björck M; Brodmann M; Cohnert T; Collet J-P; Czerny M; De Carlo M; Debus S; Espinola-Klein C; Kahan T; Kownator S; Mazzolai L; Naylor AR; Roffi M; Röther J; Sprynger M; Tendera M; Tepe G; Venermo M; Vlachopoulos C; Desormais I; Document Reviewers; Widimsky P; Kolh P; Agewall S; Bueno H; Coca A; De Borst GJ; Delgado V; Dick F; Erol C; Ferrini M; Kakkos S; Katus HA; Knuuti J; Lindholt J; Mattle H; Pieniazek P; Piepoli MF; Scheinert D; Sievert H; Simpson I; Sulzenko J; Tamargo J; Tokgozoglu L; Torbicki A; Tsakountakis N; Tuñón J; Vega de Ceniga M; Windecker S; Zamorano JL
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2018;38(2):246-253

Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography.

Brolin EB; Agewall S; Cederlund K; Ekenbäck C; Henareh L; Malmqvist K; Rück A; Svensson A; Tornvall P
Article: EUROPEAN HEART JOURNAL. 2018;39(3):213-260

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Valgimigli M; Bueno H; Byrne RA; Collet J-P; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann F-J; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies
Article: EUROPEAN HEART JOURNAL. 2018;39(3):e1-e33

Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

Collet J-P; Roffi M; Byrne RA; Costa F; Valgimigli M; Task Force for the Management of Dual Antiplatelet; ESC Scientific Document Group; Task Force for the Management of Dual Antiplatelet
Article: EUROPEAN HEART JOURNAL. 2018;39(2):119-177

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Ibanez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimský P; ESC Scientific Document Group
Article: KARDIOLOGIA POLSKA. 2018;76(2):229-313

[2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.].

Ibanez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimský P
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2018;71(1):42.e1-42.e58

Actualización ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboración con la EACTS

de Trabajo: Marco Valgimigli AMDG; Bueno H; Byrne RA; Collet J-P; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann F-J; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine CAGN; del documento: Lina Badimon R; Vranckx P; Agewall S; Andreotti F; Antman E; Barbato E; Bassand J-P; Bugiardini R; Cikirikcioglu M; Cuisset T; De Bonis M; Delgado V; Fitzsimons D; Gaemperli O; Galiè N; Gilard M; Hamm CW; Ibáñez B; Iung B; James S; Knuuti J; Landmesser U; Leclercq C; Lettino M; Lip G; Piepoli MF; Pierard L; Schwerzmann M; Sechtem U; Simpson IA; Uva MS; Stabile E; Storey RF; Tendera M; Van de Werf F; Verheugt F; Aboyans V
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2018;53(1):34-78

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.

Valgimigli M; Bueno H; Byrne RA; Collet J-P; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann F-J; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN; ESC Scientific Document Group
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;249:274-281

Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative.

Agewall S; Tjessem LH; Rossignol P; Zannad F; Atar D; Lamiral Z; Machu J-L; Dickstein K; Kjekshus J; von Lueder TG; Girerd N; High Risk Myocardial Infarction Database Initiativ
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(12):1082

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Ibánez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimský P
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(12):1082.e1-1082.e61

Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST

Ibáñez B; James S; Agewall S; Antunes MJ; Bucciarelli-Ducci C; Bueno H; Caforio ALP; Crea F; Goudevenos JA; Halvorsen S; Hindricks G; Kastrati A; Lenzen MJ; Prescott E; Roffi M; Valgimigli M; Varenhorst C; Vranckx P; Widimsk P; Collet J-P; Kristensen SD; Aboyans V; Baumbach A; Bugiardini R; Coman IM; Delgado V; Fitzsimons D; Gaemperli O; Gershlick AH; Gielen S; Harjola V-P; Katus HA; Knuuti J; Kolh P; Leclercq C; Lip GYH; Morais J; Neskovic AN; Neumann F-J; Niessner A; Piepoli MF; Richter DJ; Shlyakhto E; Simpson IA; Steg G; Terkelsen CJ; Thygesen K; Windecker S; Zamorano JL; Zeymer U
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):232

Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis.

Deyab G; Hokstad I; Whist JE; Smastuen MC; Agewall S; Lyberg T; Ronda N; Mikkelsen K; Hjeltnes G; Hollan I
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2017;52(4):616-664

2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Falk V; Baumgartner H; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Muñoz DR; Rosenhek R; Sjögren J; Tornos Mas P; Vahanian A; Walther T; Wendler O; Windecker S; Zamorano JL; ESC Scientific Document Group
Article: CLINICAL RESEARCH IN CARDIOLOGY. 2017;106(9):711-721

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.

Fröhlich H; Torres L; Täger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Article: EUROPEAN HEART JOURNAL. 2017;38(32):2473-2479

Comprehensive efforts to increase adherence to statin therapy.

Vonbank A; Agewall S; Kjeldsen KP; Lewis BS; Torp-Pedersen C; Ceconi C; Funck-Brentano C; Kaski JC; Niessner A; Tamargo J; Walther T; Wassmann S; Rosano G; Schmidt H; Saely CH; Drexel H
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2017;120(3):341-346

Effect of Myocardial Infarction With Nonobstructive Coronary Arteries on Physical Capacity and Quality-of-Life.

Daniel M; Agewall S; Caidahl K; Collste O; Ekenbäck C; Frick M; Y-Hassan S; Henareh L; Jernberg T; Malmqvist K; Schenck-Gustafsson K; Sörensson P; Sundin Ö; Hofman-Bang C; Tornvall P
Journal article: EUROPEAN HEART JOURNAL. 2017;38(suppl_1)

P4392Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status

Agewall S; Tjessum L; Rossignol P; Zannad F; Atar D; Von Lueder T; Lamiral Z; Machu JL; Kjekshus J; Girerd N
Article: BMC CARDIOVASCULAR DISORDERS. 2017;17(1):199

The value of a new cardiac magnetic resonance imaging protocol in Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA) - a case-control study using historical controls from a previous study with similar inclusion criteria.

Tornvall P; Brolin EB; Caidahl K; Cederlund K; Collste O; Daniel M; Ekenbäck C; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Sundqvist M; Sörensson P; Ugander M; Agewall S
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2017;238:97-104

Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure.

Fröhlich H; Raman N; Täger T; Schellberg D; Goode KM; Kazmi S; Grundtvig M; Hole T; Cleland JGF; Katus HA; Agewall S; Clark AL; Atar D; Frankenstein L
Article: GIORNALE ITALIANO DI CARDIOLOGIA. 2017;18(7):547-612

[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].

Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM
Article: EUROPEAN HEART JOURNAL. 2017;38(22):1710-1716

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.

Niessner A; Tamargo J; Morais J; Koller L; Wassmann S; Husted SE; Torp-Pedersen C; Kjeldsen K; Lewis BS; Drexel H; Kaski JC; Atar D; Storey RF; Lip GYH; Verheugt FWA; Agewall S
Article: INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. 2017;24(3):321-419

2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

F Piepoli M
Article: BMC MEDICAL INFORMATICS AND DECISION MAKING. 2017;17(1):40

Automatic identification of variables in epidemiological datasets using logic regression.

Lorenz MW; Abdi NA; Scheckenbach F; Pflug A; Bülbül A; Catapano AL; Agewall S; Ezhov M; Bots ML; Kiechl S; Orth A; PROG-IMT study group
Article: EUROPACE. 2017;19(2):190-225

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Gorenek B; Pelliccia A; Benjamin EJ; Boriani G; Crijns HJ; Fogel RI; Van Gelder IC; Halle M; Kudaiberdieva G; Lane DA; Larsen TB; Lip GYH; Løchen M-L; Marín F; Niebauer J; Sanders P; Tokgozoglu L; Vos MA; Van Wagoner DR; Fauchier L; Savelieva I; Goette A; Agewall S; Chiang C-E; Figueiredo M; Stiles M; Dickfeld T; Patton K; Piepoli M; Corra U; Marques-Vidal PM; Faggiano P; Schmid J-P; Abreu A
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(2):115.e1-115.e64

Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias

de Dislipemias GDTDTDL; de la European Association for Cardiovascular Prev DCLCE; de Trabajo AMDG; Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen M-R; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; adicional C; Cooney M-T; del documento R; Badimon L; Funck-Brentano C; Agewall S; Barón-Esquivias G; Borén J; Bruckert E; Cordero A; Corsini A; Giannuzzi P; Gueyffier F; Krstačić G; Lettino M; Lionis C; Lip GYH; Marques-Vidal P; Milicic D; Pedro-Botet J; Piepoli MF; Rigopoulos AG; Ruschitzka F; Tuñón J; von Eckardstein A; Vrablik M; Weiss TW; Williams B; Windecker S; Zimlichman R
Article: EUROPEAN HEART JOURNAL. 2017;38(3):143-153

ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

Agewall S; Beltrame JF; Reynolds HR; Niessner A; Rosano G; Caforio ALP; De Caterina R; Zimarino M; Roffi M; Kjeldsen K; Atar D; Kaski JC; Sechtem U; Tornvall P; WG on Cardiovascular Pharmacotherapy
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2017;24(1):4-40

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Gorenek B; Pelliccia A; Benjamin EJ; Boriani G; Crijns HJ; Fogel RI; Van Gelder IC; Halle M; Kudaiberdieva G; Lane DA; Bjerregaard Larsen T; Lip GYH; Løchen M-L; Marin F; Niebauer J; Sanders P; Tokgozoglu L; Vos MA; Van Wagoner DR; Document reviewers:; Fauchier L; Savelieva I; Goette A; Agewall S; Chiang C-E; Figueiredo M; Stiles M; Dickfeld T; Patton K; Piepoli M; Corra U; Manuel Marques-Vidal P; Faggiano P; Schmid J-P; Abreu A
Article: PLOS ONE. 2017;12(2):e0169830

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Deyab G; Hokstad I; Whist JE; Småstuen MC; Agewall S; Lyberg T; Bottazzi B; Meroni PL; Leone R; Hjeltnes G; Hollan I
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19(1):9-42

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Barón-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol Ç; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GYH; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Vaz Carneiro A; Windecker S; Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(1):50.e1-50.e84

2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS

Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2017;70(1):1609-1678

2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS.

Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castellá M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Alexandru Popescu B; Schotten U; Van Putte B; Vardas P
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(12):1167.e1-1167.e85

Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

de de de de de de de de de de de de de de de de de GDTDTDT; de Trabajo: Piotr Ponikowski AMDG; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; González-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P; del documento: Gerasimos Filippatos R; McMurray JJV; Aboyans V; Achenbach S; Agewall S; Al-Attar N; Atherton JJ; Bauersachs J; Camm AJ; Carerj S; Ceconi C; Coca A; Elliott P; Erol Ç; Ezekowitz J; Fernández-Golfín C; Fitzsimons D; Guazzi M; Guenoun M; Hasenfuss G; Hindricks G; Hoes AW; Iung B; Jaarsma T; Kirchhof P; Knuuti J; Kolh P; Konstantinides S; Lainscak M; Lancellotti P; Lip GYH; Maisano F; Mueller C; Petrie MC; Piepoli MF; Priori SG; Torbicki A; Tsutsui H; van Veldhuisen DJ; Windecker S; Yancy C; Zamorano JL
Article: EUROPACE. 2016;18(11):1609-1678

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GYH; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2016;50(5):e1-e88

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; Agewall S; Camm J; Baron Esquivias G; Budts W; Carerj S; Casselman F; Coca A; De Caterina R; Deftereos S; Dobrev D; Ferro JM; Filippatos G; Fitzsimons D; Gorenek B; Guenoun M; Hohnloser SH; Kolh P; Lip GYH; Manolis A; McMurray J; Ponikowski P; Rosenhek R; Ruschitzka F; Savelieva I; Sharma S; Suwalski P; Tamargo JL; Taylor CJ; Van Gelder IC; Voors AA; Windecker S; Zamorano JL; Zeppenfeld K
Article: LAKARTIDNINGEN. 2016;113:D7HM

[A healthy lifestyle in focus of new guidelines].

Perk J; Agewall S; Kiessling A
Article: EUROPEAN HEART JOURNAL. 2016;37(39):2999-3058

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Catapano AL; Graham I; De Backer G; Wiklund O; Chapman MJ; Drexel H; Hoes AW; Jennings CS; Landmesser U; Pedersen TR; Reiner Ž; Riccardi G; Taskinen M-R; Tokgozoglu L; Verschuren WMM; Vlachopoulos C; Wood DA; Zamorano JL; Cooney M-T; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2016;37(38):2893-2962

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Kirchhof P; Benussi S; Kotecha D; Ahlsson A; Atar D; Casadei B; Castella M; Diener H-C; Heidbuchel H; Hendriks J; Hindricks G; Manolis AS; Oldgren J; Popescu BA; Schotten U; Van Putte B; Vardas P; ESC Scientific Document Group
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(10):939

2016 European Guidelines on cardiovascular disease prevention in clinical practice.

Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Richard Hobbs FD; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; Bart van der Worp H; van Dis I; Monique Verschuren WM
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(10):939.e1-939.e87

Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica

Grupo de de de de de de de de de de de de de d SDTCDTC; de trabajo: Massimo F. Piepoli AMDG; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; Binno CAS; De Backer RDDG; Roffi M; Aboyans V; Bachl N; Bueno H; Carerj S; Cho L; Cox J; De Sutter J; Egidi G; Fisher M; Fitzsimons D; Franco OH; Guenoun M; Jennings C; Jug B; Kirchhof P; Kotseva K; Lip GYH; Mach F; Mancia G; Bermudo FM; Mezzani A; Niessner A; Ponikowski P; Rauch B; Rydén L; Stauder A; Turc G; Wiklund O; Windecker S; Zamorano JL
Article: EUROPEAN HEART JOURNAL. 2016;37(36):2768-2801

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).

Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GYH; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; ESC Scientific Document Group
Article: ATHEROSCLEROSIS. 2016;252:207-274

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members:; Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; Bart van der Worp H; van Dis I; Verschuren WMM
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18(8):891-975

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; González-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P; Authors/Task Force Members; Document Reviewers
Article: EUROPEAN HEART JOURNAL. 2016;37(29):2315-2381

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; Binno S; ESC Scientific Document Group
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(11):NP1-NP96

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members; Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; Additional Contributor: Simone Binno (Italy); Document Reviewers:; De Backer G; Roffi M; Aboyans V; Bachl N; Bueno H; Carerj S; Cho L; Cox J; De Sutter J; Egidi G; Fisher M; Fitzsimons D; Franco OH; Guenoun M; Jennings C; Jug B; Kirchhof P; Kotseva K; Lip GYH; Mach F; Mancia G; Bermudo FM; Mezzani A; Niessner A; Ponikowski P; Rauch B; Rydén L; Stauder A; Turc G; Wiklund O; Windecker S; Zamorano JL
Article: INTERNATIONAL ANGIOLOGY. 2016;35(2):217-231

UEMS training requirements for angiology and vascular medicine: european standards of postgraduate medical specialist training (ETR Document).

Catalano M; Poredos P; Brodmann M; Wautrecht JC; Carpentier P; Roztocil K; Nikol S; Dimakakos EP; Marakomichelakis G; Pecsvarady Z; Carlizza A; Sieron A; Stanek A; Olinic D; Stvrtinova V; Kozak M; Agewall S; Amann-Vesti B; Gallino A; Fitzgerald P; Colgan MP
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(2):177.e1-177.e62

Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar

Galiè N; Humbert M; Vachiery J-L; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Noordegraaf AV; Beghetti M; Ghofrani A; Sánchez MÁG; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M; Aboyans V; Carneiro AV; Achenbach S; Agewall S; Allanore Y; Asteggiano R; Badano LP; Barberà JA; Bouvaist H; Bueno H; Byrne RA; Carerj S; Castro G; Erol Ç; Falk V; Funck-Brentano C; Gorenflo M; Grantonc J; Iung B; Kiely DG; Kirchhof P; Kjellstrom B; Landmesser U; Lekakis J; Lionis C; Lip GYH; Orfanos SE; Park MH; Piepoli MF; Ponikowski P; Revel M-P; Rigau D; Rosenkranz S; Völler H; Zamorano JL
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(2):176.e1-176.e77

Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca

de de de Cardiology GDTDTDT; Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck K-H; Hernández-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; Kolh P; Lip GYH; Agewall S; Barón-Esquivias G; Boriani G; Budts W; Bueno H; Capodanno D; Carerj S; Crespo-Leiro MG; Czerny M; Deaton C; Dobrev D; Erol Ç; Galderisi M; Gorenek B; Kriebel T; Lambiase P; Lancellotti P; Lane DA; Lang I; Manolis AJ; Morais J; Moreno J; Piepoli MF; Rutten FH; Sredniawa B; Zamorano JL; Zannad F
Article: EUROPEAN HEART JOURNAL. 2016;37(3):267-315

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

Roffi M; Patrono C; Collet J-P; Mueller C; Valgimigli M; Andreotti F; Bax JJ; Borger MA; Brotons C; Chew DP; Gencer B; Hasenfuss G; Kjeldsen K; Lancellotti P; Landmesser U; Mehilli J; Mukherjee D; Storey RF; Windecker S; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2016;37(1):67-119

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N; Humbert M; Vachiery J-L; Gibbs S; Lang I; Torbicki A; Simonneau G; Peacock A; Vonk Noordegraaf A; Beghetti M; Ghofrani A; Gomez Sanchez MA; Hansmann G; Klepetko W; Lancellotti P; Matucci M; McDonagh T; Pierard LA; Trindade PT; Zompatori M; Hoeper M; ESC Scientific Document Group
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2016;23(2):194-205

Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.

Willeit P; Thompson SG; Agewall S; Bergström G; Bickel H; Catapano AL; Chien K-L; de Groot E; Empana J-P; Etgen T; Franco OH; Iglseder B; Johnsen SH; Kavousi M; Lind L; Liu J; Mathiesen EB; Norata GD; Olsen MH; Papagianni A; Poppert H; Price JF; Sacco RL; Yanez DN; Zhao D; Schminke U; Bülbül A; Polak JF; Sitzer M; Hofman A; Grigore L; Dörr M; Su T-C; Ducimetière P; Xie W; Ronkainen K; Kiechl S; Rundek T; Robertson C; Fagerberg B; Bokemark L; Steinmetz H; Ikram MA; Völzke H; Lin H-J; Plichart M; Tuomainen T-P; Desvarieux M; McLachlan S; Schmidt C; Kauhanen J; Willeit J; Lorenz MW; Sander D; PROG-IMT study group
Article: KARDIOLOGIA POLSKA. 2016;74(9):821-936

[2016 European Guidelines on cardiovascular disease prevention in clinical practice].

Piepoli MF; Hoes AW; Agewall S; Albus C; Brotons C; Catapano AL; Cooney M-T; Corrà U; Cosyns B; Deaton C; Graham I; Hall MS; Hobbs FDR; Løchen M-L; Löllgen H; Marques-Vidal P; Perk J; Prescott E; Redon J; Richter DJ; Sattar N; Smulders Y; Tiberi M; van der Worp HB; van Dis I; Verschuren WMM; Binno S
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2016;69(1):69.e1-69.e49

Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa

la Asociación Europea de de de infecciosa APDCCYL; Habib G; Lancellotti P; Antunes MJ; Bongiorni MG; Casalta J-P; del Zotti F; Dulgheru R; Khoury GE; Erba PA; Iung B; Miró JM; Mulder BJ; Plonska-Gosciniak E; Price S; Roos-Hesselink J; Snygg-Martin U; Thuny F; Mas PT; Vilacosta I; Zamorano JL; Erol Ç; Nihoyannopoulos P; Aboyans V; Agewall S; Athanassopoulos G; Aytekin S; Benzer W; Bueno H; Broekhuizen L; Carerj S; Cosyns B; de Backer J; de Bonis M; Dimopoulos K; Donal E; Drexel H; Flachskampf FA; Hall R; Halvorsen S; Hoen B; Kirchhof P; Lainscak M; Leite-Moreira AF; Lip GYH; Mestres CA; Piepoli MF; Punjabi PP; Rapezzi C; Rosenhek R; Siebens K; Tamargo J; Walker DM
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2015;68(12):1126.e1-1126.e46

Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de las enfermedades del pericardio

Surgery TEAFC-T; Adler Y; Charron P; Imazio M; Badano L; Barón-Esquivias G; Bogaert J; Brucato A; Gueret P; Klingel K; Lionis C; Maisch B; Mayosi B; Pavie A; Ristić AD; Tenas MS; Seferovic P; Swedberg K; Tomkowski W; Achenbach S; Agewall S; Al-Attar N; Ferrer JA; Arad M; Asteggiano R; Bueno H; Caforio ALP; Carerj S; Ceconi C; Evangelista A; Flachskampf F; Giannakoulas G; Gielen S; Habib G; Kolh P; Lambrinou E; Lancellotti P; Lazaros G; Linhart A; Meurin P; Nieman K; Piepoli MF; Price S; Roos-Hesselink J; Roubille F; Ruschitzka F; Sauleda JS; Sousa-Uvaa M; Voigt JU; Zamorano JL
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2015;68(12):1125.e1-1125.e64

Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el tratamiento de los síndromes coronarios agudos en pacientes sin elevación persistente del segmento ST

Roffi M; Patrono C; Collet J-P; Mueller C; Valgimigli M; Andreotti F; Bax JJ; Borger MA; Brotons C; Chew DP; Gencer B; Hasenfuss G; Kjeldsen K; Lancellotti P; Landmesser U; Mehilli J; Mukherjee D; Storey RF; Windecker S; Baumgartner H; Gaemperli O; Achenbach S; Agewall S; Badimon L; Baigent C; Bueno H; Bugiardini R; Carerj S; Casselman F; Cuisset T; Erol Ç; Fitzsimons D; Halle M; Hamm C; Hildick-Smith D; Huber K; Iliodromitis E; James S; Lewis BS; Lip GYH; Piepoli MF; Richter D; Rosemann T; Sechtem U; Steg PG; Vrints C; Zamorano JL
Article: EUROPEAN HEART JOURNAL. 2015;36(44):3075-3128

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Habib G; Lancellotti P; Antunes MJ; Bongiorni MG; Casalta J-P; Del Zotti F; Dulgheru R; El Khoury G; Erba PA; Iung B; Miro JM; Mulder BJ; Plonska-Gosciniak E; Price S; Roos-Hesselink J; Snygg-Martin U; Thuny F; Tornos Mas P; Vilacosta I; Zamorano JL; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2015;36(42):2921-2964

2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).

Adler Y; Charron P; Imazio M; Badano L; Barón-Esquivias G; Bogaert J; Brucato A; Gueret P; Klingel K; Lionis C; Maisch B; Mayosi B; Pavie A; Ristic AD; Sabaté Tenas M; Seferovic P; Swedberg K; Tomkowski W; ESC Scientific Document Group
Article: EUROPEAN HEART JOURNAL. 2015;36(41):2793-2867

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck K-H; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; ESC Scientific Document Group
Article: EUROPACE. 2015;17(11):1601-1687

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Priori SG; Blomström-Lundqvist C; Mazzanti A; Blom N; Borggrefe M; Camm J; Elliott PM; Fitzsimons D; Hatala R; Hindricks G; Kirchhof P; Kjeldsen K; Kuck K-H; Hernandez-Madrid A; Nikolaou N; Norekvål TM; Spaulding C; Van Veldhuisen DJ; Task Force for the Management of Patients with Ven
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17(11):1144-1151

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.

von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P; High-Risk Myocardial Infarction Database Initiativ
Article: EUROPEAN HEART JOURNAL. 2015;36(40):2677-2680

Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.

Rosano GMC; Lewis B; Agewall S; Wassmann S; Vitale C; Schmidt H; Drexel H; Patak A; Torp-Pedersen C; Kjeldsen KP; Tamargo J
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2015;116(6):838-844

Risk Factors and Markers for Acute Myocardial Infarction With Angiographically Normal Coronary Arteries.

Daniel M; Ekenbäck C; Agewall S; Brolin EB; Caidahl K; Cederlund K; Collste O; Eurenius L; Frick M; Younis-Hassan S; Henareh L; Jernberg T; Malmqvist K; Spaak J; Sörensson P; Hofman-Bang C; Tornvall P
Article: CIRCULATION-HEART FAILURE. 2015;8(5):887-896

Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study.

Fröhlich H; Zhao J; Täger T; Cebola R; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
Article: BMC CARDIOVASCULAR DISORDERS. 2015;15:63

Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study.

Brolin EB; Agewall S; Brismar TB; Caidahl K; Tornvall P; Cederlund K
Article: ATHEROSCLEROSIS. 2015;241(1):87-91

Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data.

Tornvall P; Gerbaud E; Behaghel A; Chopard R; Collste O; Laraudogoitia E; Leurent G; Meneveau N; Montaudon M; Perez-David E; Sörensson P; Agewall S
Journal article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(Suppl 2):1011-1012

AB0355 Anti-Rheumatic Therapy Reduces Syndecan-1 Shedding in Rheumatoid Arthritis (RA)

Hollan I; Vuong TT; Reine TM; Hjeltnes G; Lyberg T; Agewall S; Wiik A; Mikkelsen K; Førre ØT; Kolset SO
Article: CLINICA CHIMICA ACTA. 2015;443:78-84

Troponins in heart failure.

Omland T; Røsjø H; Giannitsis E; Agewall S
Article: AMERICAN HEART JOURNAL. 2015;169(2):257-265.e1

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(1):31-36

ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry.

De Blois J; Fagerland MW; Grundtvig M; Semb AG; Gullestad L; Westheim A; Hole T; Atar D; Agewall S
Article: CARDIOLOGY. 2015;131(4):209-217

The Effects of Climate Change on Cardiac Health.

De Blois J; Kjellstrom T; Agewall S; Ezekowitz JA; Armstrong PW; Atar D
Article: EUROPEAN HEART JOURNAL. 2014;35(43):3033-3069k

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Konstantinides SV; Torbicki A; Agnelli G; Danchin N; Fitzmaurice D; Galiè N; Gibbs JSR; Huisman MV; Humbert M; Kucher N; Lang I; Lankeit M; Lekakis J; Maack C; Mayer E; Meneveau N; Perrier A; Pruszczyk P; Rasmussen LH; Schindler TH; Svitil P; Vonk Noordegraaf A; Zamorano JL; Zompatori M; Task Force for the Diagnosis and Management of Acu
Article: ANGIOLOGY. 2014;65(10):932-936

Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction.

Crisby M; Henareh L; Agewall S
Article: EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 2014;31(10):517-573

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; De Hert S; Ford I; Gonzalez Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Luescher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Uva MS; Voudris V; Funck-Brentano C; Authors/Task Force Members
Article: EUROPEAN HEART JOURNAL. 2014;35(35):2383-2431

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Kristensen SD; Knuuti J; Saraste A; Anker S; Bøtker HE; Hert SD; Ford I; Gonzalez-Juanatey JR; Gorenek B; Heyndrickx GR; Hoeft A; Huber K; Iung B; Kjeldsen KP; Longrois D; Lüscher TF; Pierard L; Pocock S; Price S; Roffi M; Sirnes PA; Sousa-Uva M; Voudris V; Funck-Brentano C; Authors/Task Force Members
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2014;34(5):389-396

The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease.

Johnson J; Manouras A; Bergholm F; Brodin LÅ; Agewall S; Henareh L
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2014;34(4):322-326

Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima-media thickness.

Jogestrand T; Agewall S; Gustafsson T; Henareh L
Article: SLEEP MEDICINE. 2014;15(7):762-768

Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea.

Hall TS; Herrscher TE; Jarolim P; Fagerland MW; Jensen T; Agewall S; Atar D; Hallén J
Article: SLEEP AND BREATHING. 2014;18(2):351-358

Obstructive sleep apnea: no independent association to troponins.

Hall TS; Herrscher T; Jarolim P; Fagerland MW; Jensen T; Hallén J; Agewall S; Atar D
Article: ANGIOLOGY. 2014;65(5):443-449

Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.

Ghanavatian S; Diep LM; Bárány P; Heimbürger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
Article: LAKARTIDNINGEN. 2014;111(15):680-681

[New guidelines for diagnosis and management of stable angina pectoris. Recommendations from the European Society of Cardiology].

Agewall S
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2014;134(5):510

[New guidelines for angina pectoris].

Agewall S
Article: CURRENT ATHEROSCLEROSIS REPORTS. 2014;16(3):396

"Troponin elevation in coronary ischemia and necrosis".

Agewall S; Giannitsis E
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(10):1747-1755

Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study.

Frankenstein L; Katus HA; Grundtvig M; Hole T; de Blois J; Schellberg D; Atar D; Zugck C; Agewall S; Norwegian Heart Failure Registry steering committe
Journal article: EUROPEAN HEART JOURNAL. 2013;34(suppl_1):p5446

Presence of eNOS TT genotype is associated with a poor prognosis in patients with a previous myocardial infarction

Agewall S; Henareh L; Norman B
Article: EUROPEAN HEART JOURNAL. 2013;34(23):1708-1713b

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.

Agewall S; Cattaneo M; Collet JP; Andreotti F; Lip GYH; Verheugt FWA; Huber K; Grove EL; Morais J; Husted S; Wassmann S; Rosano G; Atar D; Pathak A; Kjeldsen K; Storey RF; ESC Working Group on Cardiovascular Pharmacology a
Article: EUROPEAN HEART JOURNAL. 2013;34(22):1621-1629

Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.

Verheugt FWA; Clemmensen P; Mehran R; Agewall S; Pocock SJ; Goldstein S; Torp-Pedersen C; Simoons ML; Borer JS; Khder YM; Burton P; Deliargyris E; McMurray JJV; Berkowitz SD; Stough WG; Zannad F
Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2013;31(3):415-421

Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.

Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2013;133(7):739

[New European guidelines for heart failure].

Agewall S
Article: LAKARTIDNINGEN. 2013;110(13-14):672-673

[New European guidelines for acute and chronic heart failure].

Agewall S
Article: LAKARTIDNINGEN. 2013;110(13-14):664

[Wanted: Politics against heart attacks].

Agewall S; Rydén L; Perk J; Rosengren A; Boman K; Hellénius M-L; Ros I
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2013;61(3):250-257

Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial.

Scheiman JM; Herlitz J; Veldhuyzen van Zanten SJ; Lanas A; Agewall S; Nauclér EC; Svedberg L-E; Nagy P
Article: JOURNAL OF INTERNAL MEDICINE. 2013;273(2):189-196

Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study.

Collste O; Sörensson P; Frick M; Agewall S; Daniel M; Henareh L; Ekenbäck C; Eurenius L; Guiron C; Jernberg T; Hofman-Bang C; Malmqvist K; Nagy E; Arheden H; Tornvall P
Journal article: REVISTA PORTUGUESA DE CARDIOLOGIA. 2013;32(1):81-82

ESC/EAS Guidelines for the Management of Dyslipidaemias

Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood. D
Journal article: REVISTA PORTUGUESA DE CARDIOLOGIA. 2013;32(1):83-84

ESC/EAS Guidelines for the Management of Dyslipidaemias

Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood. D
Article: HEART. 2013;99(1):30-34

Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity.

Namtvedt SK; Hisdal J; Randby A; Agewall S; Stranden E; Somers VK; Røsjø H; Omland T
Article: ANGIOLOGY. 2012;63(7):500-503

Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis.

Agewall S; Daniel M; Eurenius L; Ekenbäck C; Skeppholm M; Malmqvist K; Hofman-Bang C; Collste O; Frick M; Henareh L; Jernberg T; Tornvall P
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2012;32(5):400-403

Echogenicity of the carotid intima-media complex and cardiovascular risk factors.

De Blois J; Stranden E; Jogestrand T; Henareh L; Agewall S
Article: CARDIOVASCULAR DIABETOLOGY. 2012;11:93

2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus.

Henareh L; Agewall S
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2012;367(4):319-328

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators; Gerstein HC; Bosch J; Dagenais GR; Díaz R; Jung H; Maggioni AP; Pogue J; Probstfield J; Ramachandran A; Riddle MC; Rydén LE; Yusuf S
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2012;367(4):309-318

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators; Bosch J; Gerstein HC; Dagenais GR; Díaz R; Dyal L; Jung H; Maggiono AP; Probstfield J; Ramachandran A; Riddle MC; Rydén LE; Yusuf S
Article: JOURNAL OF RHEUMATOLOGY. 2012;39(7):1341-1347

Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors.

Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Article: LANCET. 2012;379(9831):2053-2062

Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data.

Lorenz MW; Polak JF; Kavousi M; Mathiesen EB; Völzke H; Tuomainen T-P; Sander D; Plichart M; Catapano AL; Robertson CM; Kiechl S; Rundek T; Desvarieux M; Lind L; Schmid C; DasMahapatra P; Gao L; Ziegelbauer K; Bots ML; Thompson SG; PROG-IMT Study Group
Article: CLINICA CHIMICA ACTA. 2012;413(9-10):933-937

Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation.

Melki D; Lind S; Agewall S; Jernberg T
Article: GIORNALE ITALIANO DI CARDIOLOGIA. 2012;13(3):171-228

[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)].

Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D; European Society of Cardiology
Article: TURK KARDIYOLOJI DERNEGI ARSIVI. 2012;40 Suppl 1:5-60

[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries].

Tendera M; Aboyans V; Bartelink L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Rother J; Sievert H; van Sambeek M; Zeller T; Avrupa Kardiyoloji Derneği ESC Periferik Atardamar; Avrupa Inme Organizasyonu (ESO) tarafindan destekl
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2012;65(2):173.e1-173.e55

Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST

de Trabajo para el manejo la Sociedad Europea de GDSCAEP; Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2012;65(2):173

ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation

Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D
Article: LAKARTIDNINGEN. 2012;109(1-2):18

[Troponin can be increased in healthy persons following moderate exercise].

Agewall S
Article: CLINICAL LABORATORY. 2012;58(9-10):1029-1036

Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience.

Hall TS; Hallén J; Agewall S; Atar D; Jensen T
Article: ANGIOLOGY. 2012;63(1):17-23

Some aspects of preventing coronary heart disease.

Agewall S
Article: LAKARTIDNINGEN. 2011;108(50):2644-2645

[New European guidelines for myocardial infarction without ST-segment elevation. Quicker diagnosis saves money--demands for angiography also during weekends costs more].

Agewall S
Article: EUROPEAN HEART JOURNAL. 2011;32(23):2999-3054

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).

Hamm CW; Bassand J-P; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D; ESC Committee for Practice Guidelines
Journal article: REVISTA ESPANOLA DE CARDIOLOGIA. 2011;64(12):1168

ESC/EAS Guidelines for the management of dyslipidaemias

de de de Aterosclerosis GDTDTDT; Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D
Article: REVISTA PORTUGUESA DE CARDIOLOGIA. 2011;30(12):951

Myocardial revascularization

Wijns W; Kolh P; Danchin N; Di Mario C; Falk V; Folliguet T; Garg S; Huber K; James S; Knuuti J; Lopez-Sendon J; Marco J; Menicanti L; Ostojic M; Piepoli MF; Pirlet C; Pomar JL; Reifart N; Ribichini FL; Schalij MJ; Sergeant P; Serruys PW; Silber S; Uva MS; Taggart D; Vahanian A; Auricchio A; Bax J; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; McDonagh T; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas PE; Widimsky P; Kolh P; Alfieri O; Dunning J; Elia S; Kappetein P; Lockowandt U; Sarris G; Vouhe P; Kearney P; von Segesser L; Agewall S; Aladashvili A; Alexopoulos D; Antunes MJ; Atalar E; de la Riviere AB; Doganov A; Eha J; Fajadet J; Ferreira R; Garot J; Halcox J; Hasin Y; Janssens S; Kervinen K; Laufer G; Legrand V; Nashef SAM; Neumann F-J; Niemela K; Nihoyannopoulos P; Noc M; Piek JJ; Pirk J; Rozenman Y; Sabate M; Starc R; Thielmann M; Wheatley DJ; Windecker S; Zembala M
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2011;131(23):2340

[New European guidelines for acute myocardial infarction].

Agewall S; Atar D
Article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2011;131(22):2226

Physical exertion may cause high troponin levels.

Agewall S; Tjora S
Article: EUROPEAN HEART JOURNAL. 2011;32(22):2851-2906

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

European Stroke Organisation; Tendera M; Aboyans V; Bartelink M-L; Baumgartner I; Clément D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Röther J; Sievert H; van Sambeek M; Zeller T; ESC Committee for Practice Guidelines
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(6):422-427

Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.

Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2011;45(4):198-204

Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations.

Melki D; Lind S; Agewall S; Jernberg T
Article: EUROPEAN HEART JOURNAL. 2011;32(14):1769-1818

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

European Association for Cardiovascular Prevention; Reiner Z; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(5):812-817

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study.

Provan SA; Semb AG; Hisdal J; Stranden E; Agewall S; Dagfinrud H; Angel K; Atar D; Kvien TK
Article: JOURNAL OF RHEUMATOLOGY. 2011;38(4):606-612

Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis.

Provan SA; Angel K; Semb AG; Mowinckel P; Agewall S; Atar D; Kvien TK
Article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY. 2011;45(2):151-158

Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease.

Hallén J; Madsen L; Ladefoged S; Fagerland MW; Serebruany VL; Agewall S; Atar D
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;146(3):354-358

Gender differences among Norwegian patients with heart failure.

Brandsaeter B; Atar D; Agewall S; Norwegian Heart failure Registry
Article: CLINICAL LABORATORY. 2011;57(9-10):771-776

The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction.

Ghanavatian S; Stein RA; Atar D; Hole L; Agewall S
Article: CLINICAL LABORATORY. 2011;57(7-8):615-618

Amyotrophic lateral sclerosis (ALS), a novel rare cause of elevated plasma troponin T levels.

Von Lueder TG; Melsom MN; Atar D; Agewall S
Article: EUROPEAN HEART JOURNAL. 2010;31(20):2501-2555

Guidelines on myocardial revascularization.

Task Force on Myocardial Revascularization of the ; European Association for Percutaneous Cardiovascul; Wijns W; Kolh P; Danchin N; Di Mario C; Falk V; Folliguet T; Garg S; Huber K; James S; Knuuti J; Lopez-Sendon J; Marco J; Menicanti L; Ostojic M; Piepoli MF; Pirlet C; Pomar JL; Reifart N; Ribichini FL; Schalij MJ; Sergeant P; Serruys PW; Silber S; Sousa Uva M; Taggart D
Article: ATHEROSCLEROSIS. 2010;212(2):586-588

Patients' self-estimated likelihood of taking a statin as prescribed after different types of prognostic information.

Roshan F; Saeed M; Agewall S
Article: LANCET. 2010;376(9744):875-885

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L; SHIFT Investigators
Article: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2010;38 Suppl:S1-S52

Guidelines on myocardial revascularization.

Task Force on Myocardial Revascularization of the ; European Association for Percutaneous Cardiovascul; Kolh P; Wijns W; Danchin N; Di Mario C; Falk V; Folliguet T; Garg S; Huber K; James S; Knuuti J; Lopez-Sendon J; Marco J; Menicanti L; Ostojic M; Piepoli MF; Pirlet C; Pomar JL; Reifart N; Ribichini FL; Schalij MJ; Sergeant P; Serruys PW; Silber S; Sousa Uva M; Taggart D
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2010;30(5):354-359

Impact of physical activity and body composition on heart function and morphology in middle-aged, abdominally obese women.

Eriksson M; Uddén J; Hemmingsson E; Agewall S
Article: ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES. 2010;27(6):651-658

Intima-media thickness of common carotid and brachial arteries and prothrombin fragment 1 + 2 are associated with left ventricular diastolic dysfunction in patients with myocardial infarction.

Henareh L; Camilla J; Jogestrand T; Brodin L-A; Agewall S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2010;105(9):1229-1234

Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.

Milonas C; Jernberg T; Lindbäck J; Agewall S; Wallentin L; Stenestrand U; RIKS-HIA Group
Article: JOURNAL OF CARDIAC FAILURE. 2010;16(3):225-229

COPD predicts mortality in HF: the Norwegian Heart Failure Registry.

De Blois J; Simard S; Atar D; Agewall S; Norwegian Heart Failure Registry
Journal article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2010;55(10):a118.e1107

HIGH SENSITIVE TROPONIN T RULES OUT MYOCARDIAL INFARCTION 2 HOURS FROM ADMISSION IN CHEST PAIN PATIENTS.

Melki D; Lind S; Agewall S; Jernberg T
Journal article: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2010;130(5):466

Överbehandling av patienter med demens

Agewall S
Article: THROMBOSIS RESEARCH. 2009;124(5):526-530

Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.

Henareh L; Jogestrand T; Agewall S
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2009;29(5):372-375

Evaluation of endothelial function using finger plethysmography.

Faizi AK; Kornmo DW; Agewall S
Article: HEART AND VESSELS. 2009;24(4):260-266

Expression of heat shock proteins and nitrotyrosine in small arteries from patients with coronary heart disease.

Paier A; Agewall S; Kublickiene K
Article: HEART AND VESSELS. 2009;24(2):90-95

Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease.

Crisby M; Kublickiene K; Henareh L; Agewall S
Article: CORONARY ARTERY DISEASE. 2008;19(5):289-292

Quality of life and insulin resistance in patients with coronary heart disease.

Agewall S; Henareh L
Journal article: ARTERY RESEARCH. 2008;2(3):107

P2.03 Early Inflammation Can Predict Arterial Stiffness: A 15-Year Longitudinal Study of 102 Patients with Rheumatoid Arthtritis

Provan SA; Angel K; Semb AG; Mowinckel P; Agewall S; Atar D; Kvien TK
Journal article: ARTERY RESEARCH. 2008;2(3):107-108

P2.06 Levels of NT-proBNP are Associated with Arterial Stiffness in Patients with Rheumatoid Arthritis

Provan SA; Angel K; Mowinckel P; Agewall S; Atar D; Kvien TK
Article: LAKARTIDNINGEN. 2008;105(16):1192-1193

[Five different types of myocardial infarction defined by new guidelines].

Agewall S
Article: ATHEROSCLEROSIS. 2008;196(1):49-58

Acute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart disease.

Cruz MN; Agewall S; Schenck-Gustafsson K; Kublickiene K
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(23):2249-2255

The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.

Fox KAA; Antman EM; Montalescot G; Agewall S; SomaRaju B; Verheugt FWA; Lopez-Sendon J; Hod H; Murphy SA; Braunwald E
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2007;99(10):1357-1359

Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit.

Agewall S; Olsson T; Löwbeer C
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2007;27(1):60-66

Disturbed glucose metabolism is associated with left ventricular dysfunction using tissue Doppler imaging in patients with myocardial infarction.

Henareh L; Lind B; Brodin L-A; Agewall S
Article: CLINICAL SCIENCE. 2006;111(1):87-91

Atorvastatin normalizes endothelial function in healthy smokers.

Agewall S; Hernberg A
Article: AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. 2006;290(5):H1969-H1975

Acute responses to phytoestrogens in small arteries from men with coronary heart disease.

Cruz MN; Luksha L; Logman H; Poston L; Agewall S; Kublickiene K
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2006;354(14):1464-1476

Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

Fifth Organization to Assess Strategies in Acute I; Yusuf S; Mehta SR; Chrolavicius S; Afzal R; Pogue J; Granger CB; Budaj A; Peters RJG; Bassand J-P; Wallentin L; Joyner C; Fox KAA
Article: HAEMOSTASIS. 2006;35(6):440-444

Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.

Agewall S; Norman B
Article: ATHEROSCLEROSIS. 2006;184(1):130-136

Endothelial function in conduit and resistance arteries in men with coronary disease.

Agewall S; Henareh L; Kublickiene K
Article: KIDNEY INTERNATIONAL. 2006;69(1):178-183

Microalbuminuria in patients with previous myocardial infarction.

Henareh L; Jogestrand T; Agewall S
Article: DIABETIC MEDICINE. 2005;22(9):1212-1217

Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease.

Henareh L; Jogestrand T; Agewall S
Article: JOURNAL OF HYPERTENSION. 2005;23(7):1397-1402

Morphological changes rather than flow-mediated dilatation in the brachial artery are better indicators of the extent and severity of coronary artery disease.

Rohani M; Jogestrand T; Källner G; Jussila R; Agewall S
Article: ATHEROSCLEROSIS. 2005;179(2):311-316

Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease.

Rohani M; Jogestrand T; Ekberg M; van der Linden J; Källner G; Jussila R; Agewall S
Article: CLINICAL CARDIOLOGY. 2005;28(2):77-80

The new definition of myocardial infarction--can we use it?

Agewall S; Löwbeer C
Article: JOURNAL OF HYPERTENSION. 2005;23(1):119-125

Intima-media complex of both the brachial artery and the common carotid artery are associated with left ventricular hypertrophy in patients with previous myocardial infarction.

Agewall S; Henareh L; Jogestrand T
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2004;24(6):317-322

Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery.

Hansell J; Henareh L; Agewall S; Norman M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2004;97(1):21-24

Should oral glucose tolerance test be a routine examination after a myocardial infarction?

Henareh L; Berglund M; Agewall S
Article: CLINICAL CARDIOLOGY. 2004;27(5):271-274

Reduced quality of life after myocardial infarction in women compared with men.

Agewall S; Berglund M; Henareh L
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(3):379-383

Oral snuff impairs endothelial function in healthy snuff users.

Rohani M; Agewall S
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2004;6(1):85-93

Effect of tissue harmonic imaging and contrast upon between observer and test-retest reproducibility of left ventricular ejection fraction measurement in patients with heart failure.

Whalley GA; Gamble GD; Walsh HJ; Wright SP; Agewall S; Sharpe N; Doughty RN
Article: CLINICAL BIOCHEMISTRY. 2003;36(1):27-30

Evaluation of point-of-care test systems using the new definition of myocardial infarction.

Agewall S
Article: ATHEROSCLEROSIS. 2002;164(1):161-166

Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men.

Agewall S; Björn F
Article: CLINICAL CARDIOLOGY. 2002;25(6):287-290

Lipoprotein(a) was an independent predictor for major coronary events in treated hypertensive men.

Agewall S; Fagerberg B
Article: METABOLISM-CLINICAL AND EXPERIMENTAL. 2002;51(6):750-753

Urinary albumin excretion and insulin metabolism in clinically healthy 58-year-old men.

Agewall S; Björn F
Article: BRITISH JOURNAL OF BIOMEDICAL SCIENCE. 2002;59(3):145-149

Smoking and use of smokeless tobacco in treated hypertensive men at high coronary risk: utility of urinary cotinine determination.

Agewall S; Persson B; Lindstedt G; Fagerberg B
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(1):18-23

Post-occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated.

Agewall S; Hulthe J; Fagerberg B; Gottfridsson B; Wikstrand J
Journal article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(1):18-23

Post-occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated

Agewall S; Hulthe J; Fagerberg B; Gottfridsson B; Wikstrand J
Article: ATHEROSCLEROSIS. 2001;157(1):197-202

Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men.

Agewall S; Lindstedt G; Fagerberg B
Article: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):305-314

Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up.

Agewall S; Fagerberg B; Berglund G; Schmidt C; Wendelhag I; Wikstrand J; Risk Factor Intervention Study Group, Sweden
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2001;21(1):9-14

Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions.

Agewall S; Doughty RN; Bagg W; Whalley GA; Braatvedt G; Sharpe N
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15(1):71-74

Should we do an oral glucose tolerance test in hypertensive men with normal fasting blood-glucose?

Agewall S
Article: THROMBOSIS AND HAEMOSTASIS. 2000;84(4):571-575

Insulin sensitivity and hemostatic factors in clinically healthy 58-year-old men.

Agewall S; Bokemark L; Wikstrand J; Lindahl A; Fagerberg B
Article: STROKE. 2000;31(7):1526-1531

Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness.

Schmidt C; Hulthe J; Wikstrand J; Gnarpe H; Gnarpe J; Agewall S; Fagerberg B
Article: EUROPEAN HEART JOURNAL. 2000;21(1):74-78

Does a glass of red wine improve endothelial function?

Agewall S; Wright S; Doughty RN; Whalley GA; Duxbury M; Sharpe N
Article: JOURNAL OF INTERNAL MEDICINE. 1999;246(5):489-495

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.

Agewall S
Article: HEART. 1999;82(1):93-95

Handgrip exercise increases postocclusion hyperaemic brachial artery dilatation.

Agewall S; Whalley GA; Doughty RN; Sharpe N
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1999;12(S4):144a

E023: The metabolic syndrome in hypertensive men: High risk of cardiovascular disease that may be reduced.

Fagerberg B; Wikstrand J; Agewall S
Article: STROKE. 1999;30(2):299-305

Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension.

Fagerberg B; Gnarpe J; Gnarpe H; Agewall S; Wikstrand J
Article: STROKE. 1998;29(11):2329-2333

Stroke was predicted by dimensions of quality of life in treated hypertensive men.

Agewall S; Wikstrand J; Fagerberg B
Article: JOURNAL OF HYPERTENSION. 1998;16(4):537-541

Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.

Agewall S; Wikstrand J; Fagerberg B
Article: AMERICAN JOURNAL OF HYPERTENSION. 1998;11(1 Pt 1):14-22

Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: a randomized intervention study.

Fagerberg B; Wikstrand J; Berglund G; Samuelsson O; Agewall S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1997;80(2):164-169

Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.

Agewall S; Wikstrand J; Ljungman S; Fagerberg B
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1997;10(S2):206a

L30: Stroke is predicted by dimensions of quality of life in treated hypertensive men

Agewall S; Wikstrand J; Fagerberg B
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1996;26(11):960-965

Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans.

Fagerberg B; Wiklund O; Agewall S; Camejo G; Wikstrand RJ
Article: ANGIOLOGY. 1996;47(10):963-972

Risk factors that predict development of microalbuminuria in treated hypertensive men. The Risk Factor Intervention Study Group.

Agewall S; Fagerberg B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1996;16(8):971-977

Atherosclerotic disease in the femoral artery in hypertensive patients at high cardiovascular risk. The value of ultrasonographic assessment of intima-media thickness and plaque occurrence. Risk Intervention Study (RIS) Group.

Suurküla M; Fagerberg B; Wendelhag I; Agewall S; Wikstrand J
Article: AMERICAN JOURNAL OF HYPERTENSION. 1996;9(6):545-550

Negative feelings (discontent) predict progress of intima-media thickness of the common carotid artery in treated hypertensive men at high cardiovascular risk.

Agewall S; Wikstrand J; Dahlöf C; Fagerberg B
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 1996;16(3):462-470

Multiple risk intervention in high-risk hypertensive patients. A 3-year ultrasound study of intima-media thickness and plaques in the carotid artery. Risk Intervention Study (RIS) Group.

Suurküla M; Agewall S; Fagerberg B; Wendelhag I; Wikstrand J
Article: HAEMOSTASIS. 1996;26(1):45-57

Femoral artery wall morphology, hemostatic factors and intermittent claudication: ultrasound study in men at high and low risk for atherosclerotic disease.

Agewall S; Wikstrand J; Wendelhag I; Tengborn L; Fagerberg B
Article: JOURNAL OF HYPERTENSION. 1995;13(12 Pt 1):1471-1477

A randomized study of quality of life during multiple risk factor intervention in treated hypertensive men at high cardiovascular risk.

Agewall S; Wikstrand J; Dahlöf C; Fagerberg B
Article: STROKE. 1995;26(6):956-960

Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk.

Agewall S; Fagerberg B; Attvall S; Wendelhag I; Urbanavicius V; Wikstrand J
Article: JOURNAL OF HYPERTENSION. 1995;13(4):463-469

Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus.

Agewall S; Wikstrand J; Ljungman S; Fagerberg B
Article: AMERICAN JOURNAL OF HYPERTENSION. 1995;8(4 Pt 1):337-342

Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.

Agewall S; Wikstrand J; Ljungman S; Herlitz H; Fagerberg B
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1995;8(4_Pt_2):35a

Thursday, May 18, 12:15 pmLow general contentment is independently associated with progress of the intima-media thickness in the common carotid artery in treated hypertensive men.

Agewall S; Wikstrand J; Dahlöf C; Fagerberg B
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 1995;8(4_Pt_2):188a

D9URINARY ALBUMIN EXCRETION IS ASSOCIATED WITH INTIMA-MEDIA THICKNESS OF THE CAROTID ARTERY IN HYPERTENSIVE MEN WITH NON-INSULIN-DEPENDENT DIABETES MELLITUS

Agewall S; Wikstrand J; Ljungman S; Fagerberg B
Article: JOURNAL OF INTERNAL MEDICINE. 1995;237(2):195-203

Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive men. Risk Factor Intervention Study Group.

Agewall S; Fagerberg B; Attvall S; Ljungman S; Urbanavicius V; Tengborn L; Wikstrand J
Article: JOURNAL OF INTERNAL MEDICINE. 1995;237(1):19-26

The cost-effectiveness of a cardiovascular multiple-risk-factor intervention programme in treated hypertensive men.

Johannesson M; Agewall S; Hartford M; Hedner T; Fagerberg B
Journal article: JOURNAL OF INTERNAL MEDICINE. 1994;236(6):651-659

The efficacy of multiple risk factor intervention in treated hypertensive men during long-term follow up. Risk Factor Intervention Study Group.

Agewall S; Wikstrand J; Samuelsson O; Persson B; Andersson OK; Fagerberg B
Journal article: BLOOD COAGULATION & FIBRINOLYSIS. 1994;5(6):895-904

Carotid artery wall morphology, haemostatic factors and cardiovascular disease. An ultrasound study in men at high and low risk for atherosclerotic disease.

Agewall S; Wikstrand J; Suurküla M; Tengborn L; Fagerberg B
Journal article: CLINICAL CHEMISTRY. 1994;40(11 Pt 1):2057-2063

Is carbohydrate-deficient transferrin in serum useful for detecting excessive alcohol consumption in hypertensive patients?

Fagerberg B; Agewall S; Berglund A; Wysocki M; Lundberg PA; Lindstedt G
Journal article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1994;79(3):712-715

Carbohydrate-deficient transferrin is associated with insulin sensitivity in hypertensive men.

Fagerberg B; Agewall S; Urbanavicius V; Attvall S; Lundberg PA; Lindstedt G
Journal article: ARTERIOSCLEROSIS AND THROMBOSIS. 1994;14(8):1297-1304

Ultrasound evaluation of atherosclerotic manifestations in the carotid artery in high-risk hypertensive patients. Risk Intervention Study (RIS) Group.

Suurküla M; Agewall S; Fagerberg B; Wendelhag I; Widgren B; Wikstrand J
Journal article: JOURNAL OF HYPERTENSION. 1993;11(4):461-469

Microalbuminuria in treated hypertensive men at high risk of coronary disease. The Risk Factor Intervention Study Group.

Agewall S; Persson B; Samuelsson O; Ljungman S; Herlitz H; Fagerberg B
Journal article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 1993;3(3):128-135

MULTIPLE CARDIOVASCULAR RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN - WHAT CAN BE ACHIEVED

AGEWALL S; FAGERBERG B; SAMUELSSON O; PERSSON B; HEDNER T; ANDERSSON OK; WIKSTRAND J; BERGLUND G
Journal article: JOURNAL OF INTERNAL MEDICINE. 1991;229(2):151-158

Reflexogenic neuronal and humoral responses to selective stimulation of low-pressure cardiopulmonary receptors in man.

Agewall S; Rhea B; Persson B; Karlberg B; Wallin G; Andersson OK
Journal article: JOURNAL OF HYPERTENSION. 1988;6(4):s741

115 Adrenaline-induced increases in plasma noradrenaline in man are due to an increased nerve activity rather than to prejunctional modulation of transmitter release

Andersson OK; Hjemdahl P; Persson B; Wysocki M; Agewall S; Wallin G
Visa fler

Alla övriga publikationer

Letter: JACC-CARDIOVASCULAR IMAGING. 2023;16(12):1626-1628

CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries.

Sundqvist MG; Sörensson P; Ekenbäck C; Lundin M; Agewall S; Brolin EB; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Winnberg O; Caidahl K; Ugander M; Tornvall P
Letter: JACC-CARDIOVASCULAR IMAGING. 2023;16(1):128-129

Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

Nickander J; Ekenbäck C; Agewall S; Bacsovics Brolin E; Caidahl K; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Winnberg O; Sundqvist M; Ugander M; Tornvall P; Sörensson P
Preprint: MEDRXIV. 2022

Cardiovascular magnetic resonance imaging after normal echocardiography in myocardial infarction with nonobstructed coronary arteries

Sundqvist M; Sörensson P; Ekenbäck C; Lundin M; Agewall S; Bacsovics Brolin E; Cederlund K; Collste O; Daniel M; Jensen J; Y-Hassan S; Henareh L; Hofman-Bang C; Lyngå P; Maret E; Sarkar N; Spaak J; Winnberg O; Caidahl K; Ugander M; Tornvall P
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(4):406-419

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Tamargo J; Kjeldsen KP; Delpón E; Semb AG; Cerbai E; Dobrev D; Savarese G; Sulzgruber P; Rosano G; Borghi C; Wassmann S; Torp-Pedersen CT; Agewall S; Drexel H; Baumgartner I; Lewis B; Ceconi C; Kaski JC; Niessner A
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(3):302-310

Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.

Drexel H; Pocock SJ; Lewis BS; Saely CH; Kaski JC; Rosano GMC; Tautermann G; Huber K; Dopheide JF; Mader A; Niessner A; Savarese G; Schmidt TA; Semb AG; Tamargo J; Wassmann S; Clodi M; Kjeldsen KP; Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(2):187-210

Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing.

El Hadidi S; Rosano G; Tamargo J; Agewall S; Drexel H; Kaski JC; Niessner A; Lewis BS; Coats AJS; Savarese G
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2022;8(1):85-99

The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Magavern EF; Kaski JC; Turner RM; Drexel H; Janmohamed A; Scourfield A; Burrage D; Floyd CN; Adeyeye E; Tamargo J; Lewis BS; Kjeldsen KP; Niessner A; Wassmann S; Sulzgruber P; Borry P; Agewall S; Semb AG; Savarese G; Pirmohamed M; Caulfield MJ
Conference publication: PLOS ONE. 2022;17(2):e0264628

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.

Nguyen THP; Hokstad I; Fagerland MW; Mollnes TE; Hollan I; Feinberg MW; Hjeltnes G; Eilertsen GØ; Mikkelsen K; Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(6):557-567

Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Krogager ML; Kragholm K; Thomassen JQ; Søgaard P; Lewis BS; Wassmann S; Baumgartner I; Ceconi C; Schmidt TA; Kaski JC; Drexel H; Semb AG; Agewall S; Niessner A; Savarese G; Kjeldsen KP; Borghi C; Tamargo J; Torp-Pedersen C
Review: HEART FAILURE REVIEWS. 2021;26(6):1421-1435

Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

Täger T; Atar D; Agewall S; Katus HA; Grundtvig M; Cleland JGF; Clark AL; Fröhlich H; Frankenstein L
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(5):453-459

The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials.

Drexel H; Lewis BS; Rosano GMC; Saely CH; Tautermann G; Huber K; Dopheide JF; Kaski JC; Mader A; Niessner A; Savarese G; Schmidt TA; Semb A; Tamargo J; Wassmann S; Per Kjeldsen K; Agewall S; Pocock SJ
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(2):81-82

Antiplatelet treatment in coronary syndrome.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(1):1-2

Atrial fibrillation in registries.

Agewall S
Conference publication: PLOS ONE. 2021;16(6):e0253793

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.

Nguyen THP; Fagerland MW; Deyab G; Hjeltnes G; Hollan I; Feinberg MW; Eilertsen GØ; Mikkelsen K; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(6):339-340

Focus on blood pressure and risk factor intervention.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(5):271-272

Minimizing bleeding events.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(5):284

MSc in clinical trials: a new flagship Working Group project.

Lewis BS; Agewall S; Rosano GMC
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(3):131-132

Focus on subpopulations of atrial fibrillation patients.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(4):201-202

Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):71

Lipids and antithrombotic treatment.

Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):104-114

Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Hollan I; Ronda N; Dessein P; Agewall S; Karpouzas G; Tamargo J; Niessner A; Savarese G; Rosano G; Kaski JC; Wassmann S; Meroni PL
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):86-93

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.

Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(2):97-103

The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials.

Drexel H; Rosano GMC; Lewis BS; Huber K; Vonbank A; Dopheide JF; Mader A; Niessner A; Savarese G; Wassmann S; Agewall S
Review: EUROPEAN HEART JOURNAL. 2020;41(3):407-477

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Knuuti J; Wijns W; Saraste A; Capodanno D; Barbato E; Funck-Brentano C; Prescott E; Storey RF; Deaton C; Cuisset T; Agewall S; Dickstein K; Edvardsen T; Escaned J; Gersh BJ; Svitil P; Gilard M; Hasdai D; Hatala R; Mahfoud F; Masip J; Muneretto C; Valgimigli M; Achenbach S; Bax JJ; ESC Scientific Document Group
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(1):1-2

Focus on pharma in acute coronary syndrome.

Agewall S
Editorial comment: CARDIOVASCULAR RESEARCH. 2019;115(14):e187-e188

Medical misinformation: vet the message!

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Review: CARDIAC FAILURE REVIEW. 2019;5(3):130-132

Hyperkalemia and Renin-Angiotensin-Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction.

Rosano GM; Spoletini I; Vitale C; Agewall S
Corrigendum: EUROPEAN HEART JOURNAL. 2019;40(37):3096

Corrigendum to: 2018 ESC/EACTS Guidelines on myocardial revascularization.
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(4):183-184

European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2019;40(36):3010-3012

Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.

Sulzgruber P; Wassmann S; Semb AG; Doehner W; Widimsky P; Gremmel T; Kaski JC; Savarese G; Rosano GMC; Borghi C; Kjeldsen K; Torp-Pedersen C; Schmidt TA; Lewis BS; Drexel H; Tamargo J; Atar D; Agewall S; Niessner A
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(3):125-126

Antiplatelet treatment in acute coronary syndrome. Still an issue.

Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(3):171-180

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.

Sulzgruber P; Wassmann S; Semb AG; Doehner W; Widimsky P; Gremmel T; Kaski JC; Savarese G; Rosano GMC; Borghi C; Kjeldsen K; Torp-Pedersen C; Schmidt TA; Lewis BS; Drexel H; Tamargo J; Atar D; Agewall S; Niessner A
Editorial comment: CARDIOVASCULAR DRUGS AND THERAPY. 2019;33(3):275-276

Medical Misinformation: Vet the Message!

Hill JA; Heart Group Signatories
Editorial comment: JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY. 2019;55(1):1-3

Medical misinformation: vet the message!

Hill JA; Heart Group Signatories
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2019;78:1628.3-161629

ANTIRHEUMATIC THERAPY IS NOT ASSOCIATED WITH CHANGES IN CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-PROBNP) LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Thao N; Deyab G; Fagerland M; Agewall S; Eilertsen G; Feinberg M; Mikkelsen K; Forre O; Hollan I
Editorial comment: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES. 2019;5(2):83-84

Medical misinformation: vet the message!

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):62-63

Medical misinformation: vet the message!

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):59

European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):60-61

Unsolved issues in oral anticoagulation treatment in atrial fibrillation.

Agewall S
Letter: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(2):119-121

Ivabradine for heart failure: regulatory differences in Europe and United States.

Marciniak TA; Hall TS; Atar D; Agewall S; Serebruany VL
Editorial comment: JOURNAL OF ELECTROCARDIOLOGY. 2019;53:112-113

Medical misinformation: Vet the message!
Editorial comment: HEART RHYTHM. 2019;16(3):332-333

Medical misinformation: Vet the message!

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: HYPERTENSION. 2019;73(3):506-507

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Other: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21(3):264-265

Medical misinformation: vet the message!

Hill JA
Editorial comment: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2019;277:1-2

Medical Misinformation: Vet the Message!

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2019;8(3):e011838

Medical Misinformation: Vet the Message!

Hill JA; et al
Editorial comment: EUROPEAN HEART JOURNAL. 2019;40(5):404-405

Medical Misinformation: Vet the Message!

Hill JA; following HEART Group Signatories; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-CARDIOVASCULAR INTERVENTIONS. 2019;12(2):e007796

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES. 2019;12(2):e005496

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol C; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C; All authors are HEART Group Signatories
Editorial comment: CIRCULATION-CARDIOVASCULAR IMAGING. 2019;12(2):e008809

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-GENOMIC AND PRECISION MEDICINE. 2019;12(2):e002439

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION-HEART FAILURE. 2019;12(2):e005869

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C; All authors are HEART Group Signatories.
Editorial comment: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2019;73(2):61-62

Medical Misinformation: Vet the Message!

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: CIRCULATION. 2019;139(5):571-572

Medical Misinformation.

Hill JA; Agewall S; Baranchuk A; Booz GW; Borer JS; Camici PG; Chen P-S; Dominiczak AF; Erol Ç; Grines CL; Gropler R; Guzik TJ; Heinemann MK; Iskandrian AE; Knight BP; London B; Lüscher TF; Metra M; Musunuru K; Nallamothu BK; Natale A; Saksena S; Picard MH; Rao SV; Remme WJ; Rosenson RS; Sweitzer NK; Timmis A; Vrints C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):1-2

Old and new drugs in cardiovascular pharmacotherapy.

Agewall S
Editorial comment: CARDIOLOGY. 2019;142(2):63-65

Medical Misinformation: Vet the Message!

Hill JA; HEART Group Signatories
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):47-54

Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review.

Navarese EP; Andreotti F; Raggi P; Kolodziejczak M; Buffon A; Bliden K; Tantry U; Kubica J; Sardella G; Lauten A; Agewall S; Gurbel PA; Brouwer MA
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21:423-424

Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis

Frankenstein LL; Froehlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2019;21:55

Epidemiology and long-term outcome in outpatients with chronic heart failure in north-western europe

Froehlich H; Rosenfeld N; Taeger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
Corrigendum: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):36

Corrigendum to: Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2018;272:260-266

Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction.

Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N; High-Risk Myocardial Infarction Database Initiativ
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(4):189-190

Adherence to guidelines, compliance to treatment, and treatment quality.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(4):191-192

Critical appraisal of the COMPASS trial.

Niessner A; Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(4):230-236

Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.

Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
Review: EUROPEAN HEART JOURNAL. 2018;39(33):3021-3104

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B; Mancia G; Spiering W; Agabiti Rosei E; Azizi M; Burnier M; Clement DL; Coca A; de Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen SE; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder RE; Shlyakhto E; Tsioufis C; Aboyans V; Desormais I; ESC Scientific Document Group
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(3):129-130

New input on antiplatelet treatment and registry studies.

Agewall S
Corrigendum: EUROPEAN HEART JOURNAL. 2018;39(21):1991

Corrigendum.
Editorial comment: JOURNAL OF THORACIC DISEASE. 2018;10(Suppl 17):S1934-S1937

The burden of heart failure in the general population: a clearer and more concerning picture.

von Lueder TG; Agewall S
Corrigendum: EUROPACE. 2018;20(5):738

Corrigendum.
Editorial comment: JOURNAL OF MAMMALOGY. 2018;99(2):305

Editor's Choice
Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2018;55(4):457-464

Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Aboyans V; Björck M; Brodmann M; Collet J-P; Czerny M; De Carlo M; Naylor AR; Roffi M; Tendera M; Vlachopoulos C; Ricco J-B; Task Force for the 2017 ESC Guidelines for the dia; Document Reviewers; Widimsky P; Kolh P; Dick F; Vega de Ceniga M; Piepoli MF; Sievert H; Sulzenko J; Esc Committee For Practice Guidelines Cpg; Windecker S; Aboyans V; Agewall S; Barbato E; Bueno H; Coca A; Collet J-P; Coman IM; Dean V; Delgado V; Fitzsimons D; Gaemperli O; Hindricks G; Iung B; Jüni P; Katus HA; Knuuti J; Lancellotti P; Leclercq C; McDonagh T; Piepoli MF; Ponikowski P; Richter DJ; Roffi M; Shlyakhto E; Simpson IA; Zamorano JL
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(2):65-66

Cardiovascular pharmacotherapy and real-world data.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2018;39(9):e35-e41

Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Aboyans V; Björck M; Brodmann M; Collet J-P; Czerny M; De Carlo M; Naylor AR; Roffi M; Tendera M; Vlachopoulos C; Ricco J-B; ESC Scientific Document Group
Editorial comment: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2018;52(1):1-3

Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017.

Kaluzna-Oleksy M; Aunan K; Rao-Skirbekk S; Kjellstrom T; Ezekowitz JA; Agewall S; Atar D
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2018;4(1):1

Cardiovascular pharmacotherapy.

Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2018;39:1344

Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction

Hall TS; Von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20:442

Relative efficacy of spironolactone, eplerenone, and canrenone in patients with chronic systolic heart failure - a systematic review and network meta-analysis of randomized controlled trials

Frankenstein LL; Taeger T; Froehlich H; Cleland JGF; Grundtvig M; Hole T; Katus H; Agewall S; Clark A; Atar D
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2018;20:88

Comparative effectiveness of enalapril, lisinopril and ramipril in the treatment of patients with chronic heart failure. A propensity score matched cohort study

Taeger TT; Henning F; Froehlich H; Schellberg D; Grundtvig M; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark A; Frankenstein L
Letter: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2017;137(23-24)

«Falskt positive troponinverdier» finnes ikke.

Atar D; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2017;38(44):3251

European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(4):183-184

Adherence to guidelines and registry data.

Agewall S
Corrigendum: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2017;52(4):832

Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664].

Falk V; Baumgartner H; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Muñoz DR; Rosenhek R; Sjögren J; Tornos Mas P; Vahanian A; Walther T; Wendler O; Windecker S; Zamorano JL; Roffi M; Alfieri O; Agewall S; Ahlsson A; Barbato E; Bueno H; Collet J-P; Coman IM; Czerny M; Delgado V; Fitzsimons D; Folliguet T; Gaemperli O; Habib G; Harringer W; Haude M; Hindricks G; Katus HA; Knuuti J; Kolh P; Leclercq C; McDonagh TA; Piepoli MF; Pierard LA; Ponikowski P; Rosano GMC; Ruschitzka F; Shlyakhto E; Simpson IA; Sousa-Uva M; Stepinska J; Tarantini G; Tchétché D; Aboyans V
Review: EUROPEAN HEART JOURNAL. 2017;38(36):2739-2791

2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Baumgartner H; Falk V; Bax JJ; De Bonis M; Hamm C; Holm PJ; Iung B; Lancellotti P; Lansac E; Rodriguez Muñoz D; Rosenhek R; Sjögren J; Tornos Mas P; Vahanian A; Walther T; Wendler O; Windecker S; Zamorano JL; ESC Scientific Document Group
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(3):125-126

Metabolic control, anticoagulation, and gender aspects.

Agewall S
Editorial comment: JOURNAL OF THORACIC DISEASE. 2017;9(7):1851-1854

Morphine in acute heart failure.

Agewall S
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(3):163-182

Gender differences in the effects of cardiovascular drugs.

Tamargo J; Rosano G; Walther T; Duarte J; Niessner A; Kaski JC; Ceconi C; Drexel H; Kjeldsen K; Savarese G; Torp-Pedersen C; Atar D; Lewis BS; Agewall S
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2017;76:1309-1310

CELL CHOLESTEROL TRANSPORT IN SPONDYLOARTHRITIDES AND ITS RESPONSE TO ANTI-RHEUMATIC DRUGS

Ronda N; Hokstad I; Deyab G; Greco D; Agewall S; Hjeltnes G; Whist JE; Bernini F; Hollan I
Letter: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2017;40:e11-e12

New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose.

Rubboli A; Agewall S; Huber K; Lip GYH
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(2):69-70

Coronary artery disease and arrhythmias.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(2):71-72

New ESC/EACTS Guidelines for the management of atrial fibrillation.

Agewall S; Camm J
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(1):1-2

Anticoagulation, atherosclerosis, and heart failure.

Agewall S
Conference publication: CIRCULATION. 2017;136

Influence of Left Ventricular Ejection Fraction on Fatal Outcomes After Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction

Hall TS; von Lueder TG; Zannad F; Rossignol P; Duarte K; Chouihed T; Dickstein K; Atar D; Agewall S; Girerd N
Conference publication: EUROPEAN HEART JOURNAL. 2017;38:911

Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status

Agewall S; Tjessum L; Rossignol P; Zannad F; Atar D; Von Lueder T; Lamiral Z; Machu JL; Kjekshus J; Girerd N
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2017;19:289

Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure

Froehlich HH; Torres L; Taeger T; Schellberg D; Corletto A; Kazmi S; Goode K; Grundtvig M; Hole T; Katus HA; Cleland JGF; Atar D; Clark AL; Agewall S; Frankenstein L
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;224:412-415

Cardiovascular pharmacotherapy.

Agewall S; Lewis BS; Atar D
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;221:609-621

Troponin and exercise.

Gresslien T; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(4):207-208

The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!

Agewall S
Review: EUROPEAN HEART JOURNAL. 2016;37(27):2129-2200

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Ponikowski P; Voors AA; Anker SD; Bueno H; Cleland JGF; Coats AJS; Falk V; González-Juanatey JR; Harjola V-P; Jankowska EA; Jessup M; Linde C; Nihoyannopoulos P; Parissis JT; Pieske B; Riley JP; Rosano GMC; Ruilope LM; Ruschitzka F; Rutten FH; van der Meer P; ESC Scientific Document Group
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(3):141

News from EHJCVP.

Agewall S
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:704

METHOTREXATE AND ANTI-TNF TREATMENT IMPROVE ENDOTHELIAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS

Deyab G; Hokstad I; Smastuen MC; Agewall S; Hollan I
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2016;75:992-993

ANTI-RHEUMATIC TREATMENT IS NOT ASSOCIATED WITH REDUCTION OF PENTRAXIN 3 (PTX3) IN RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) AND ANKYLOSING SPONDYLITIS (AS)

Deyab G; Hokstad I; Agewall S; Lyberg T; Whist JE; Smastuen MC; Bottazzi BB; Hjeltnes GG; Meroni PL; Hollan I
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(2):108-118

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Schmidt M; Lamberts M; Olsen A-MS; Fosbøll EL; Niessner A; Tamargo J; Rosano G; Agewall S; Kaski JC; Kjeldsen K; Lewis BS; Torp-Pedersen C
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(2):77-78

Update from EHJ CVP.

Agewall S
Review: EUROPEAN HEART JOURNAL. 2016;37(13):1015-1023

Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

Schmidt M; Lamberts M; Olsen A-MS; Fosbøll E; Niessner A; Tamargo J; Rosano G; Agewall S; Kaski JC; Kjeldsen K; Lewis BS; Torp-Pedersen C
Editorial comment: EUROPEAN HEART JOURNAL. 2016;37(3):253-255

Morphine in myocardial infarction: balancing on the tight rope.

Atar D; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(1):3-4

Annual report of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Lewis BS; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2016;2(1):1-2

Second year of a journal.

Agewall S
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

Methotrexate and Anti-Tumor Necrosis Treatment Improve Endothelial Function in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Deyab G; Hokstad I; Agewall S; Lyberg T; Whist JE; Smastuen MC; Hjeltnes G; Hollan I
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2016;68

Effect of Anti-Rheumatic Treatment on Selenium Levels in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Deyab G; Hokstad I; Smastuen MC; Agewall S; Whist JE; Hollan I
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2016;18:291

Statins attenuate but not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure

Froehlich HH; Taeger T; Goode K; Grundtvig M; Hole T; Cleland JFG; Katus HA; Agewall S; Clark AL; Frankenstein L
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2016;202:870-873

Morphine in the treatment of acute pulmonary oedema--Why?

Ellingsrud C; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(4):213

Starting up a new Journal within the European Heart Journal Family.

Agewall S
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;196:133-138

New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.

Rubboli A; Agewall S; Huber K; Lip GYH
Review: AUTOIMMUNITY REVIEWS. 2015;14(10):952-969

Prevention of cardiovascular disease in rheumatoid arthritis.

Hollan I; Dessein PH; Ronda N; Wasko MC; Svenungsson E; Agewall S; Cohen-Tervaert JW; Maki-Petaja K; Grundtvig M; Karpouzas GA; Meroni PL
Letter: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2015;135(15):1337

[Re: Different guidelines for treatment of prostate cancer].

Agewall S
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2015;192:72-81

Atherosclerosis: Recent trials, new targets and future directions.

Ladeiras-Lopes R; Agewall S; Tawakol A; Staels B; Stein E; Mentz RJ; Leite-Moreira A; Zannad F; Koenig W
Review: ANNALS OF INTERNAL MEDICINE. 2015;163(1):40-51

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis.

Navarese EP; Kolodziejczak M; Schulze V; Gurbel PA; Tantry U; Lin Y; Brockmeyer M; Kandzari DE; Kubica JM; D'Agostino RB; Kubica J; Volpe M; Agewall S; Kereiakes DJ; Kelm M
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(3):149

Cardiovascular Pharmacotherapy is moving!

Agewall S
Editorial comment: ATHEROSCLEROSIS. 2015;240(2):387-388

How to save six million people per year.

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(2):73

European Heart Journal - CVP: what is next?

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(1):46-47

End of story? Studies on prevention of reperfusion injury encounter perpetual defeats.

Atar D; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2015;1(1):1

European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family.

Agewall S
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2015;17:272

Carvedilol compared to metoprolol succinate in the treatment and prognosis of patients with stable chronic heart failure. The Carvedilol or Metoprolol Evaluation Study (COMES)

Froehlich HH; Zhao J; Taeger T; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
Review: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. 2014;134(23-24):2272-2275

[Morphine in the treatment of acute pulmonary oedema].

Ellingsrud C; Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2014;35(34):2264-2265

What does the future hold for Mayo Clinic?

Nicholls M
Review: EUROPEAN HEART JOURNAL. 2014;35(30):2001-2009

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials.

Anker SD; Agewall S; Borggrefe M; Calvert M; Jaime Caro J; Cowie MR; Ford I; Paty JA; Riley JP; Swedberg K; Tavazzi L; Wiklund I; Kirchhof P
Letter: LAKARTIDNINGEN. 2014;111(9-10):405

[Final reply: follow the Danish example].

Agewall S
Editorial comment: EUROPEAN HEART JOURNAL. 2014;35(5):266-267

Sick leave and a smoking ban.

Agewall S
Letter: LAKARTIDNINGEN. 2014;111(5):129

[Why all these guidelines?].

Agewall S
Letter: HEART. 2014;100(1):81-82

The author’s reply.

Namtvedt SK; Hisdal J; Randby A; Agewall S; Røsjø H; Omland T
Letter: HEART. 2014;100(1):81

The association between apnoea-hypopnoea index and flow-mediated dilation of brachial artery.

Kawada T
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2014;66:S170

Anti-Rheumatic Therapy Decreases Syndecan-1 Shedding in Rheumatoid Arthritis (RA)

Hollan I; Hjeltnes G; Lyberg T; Agewall S; Wiik A; Mikkelsen K; Forre OT; Vuong TT; Kolset SO
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:483-484

Cardiac troponin I for prediction of clinical outcomes and cardiac function through three months follow-up after primary percutaneous coronary intervention for ST-elevation myocardial infarction

Hall TS; Hallen J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Conference publication: EUROPEAN HEART JOURNAL. 2014;35:364

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: analysis from High Risk Myocardial Infarction Database Initiative

Von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Dickstein K; Zannad F; Rossignol P
Conference publication: INTERNATIONAL JOURNAL OF STROKE. 2014;9:27

Inflammatory markers and extent and progression of early atherosclerosis: Pooled analysis of individual participant data from 20 prospective studies of the PROG-IMT collaboration

Willeit P; Thompson SG; Agewall S; Bergstrom G; Bickel H; Catapano AL; Chien KL; de Groot E; Empana JP; Etgen T; Franco OH; Iglseder B; Johnsen SH; Kavousi M; Lind L; Liu J; Mathiesen EB; Norata GD; Olsen MH; Papagianni A; Poppert H; Price JF; Sacco RL; Yanez DN; Zhao D; Schminke U; Buelbuel A; Polak JF; Sitzer M; Hofman A; Grigore L; Doerr M; Su TC; Ducimetiere P; Xie W; Ronkainen K; Kiechl S; Rundek T; Robertson C; Fagerberg B; Bokemark L; Steinmetz H; Ikram MA; Voelzke H; Lin HJ; Plichart M; Tuomainen TP; Desvarieux M; McLachlan S; Schmidt C; Kauhanen J; Willeit J; Lorenz MW; Sander D
Conference publication: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16:68-69

Association between spironolactone added to beta blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study

Froehlich H; Frankenstein L; Katus HA; Grundtvig M; Hole T; De Blois J; Schellberg D; Atar D; Zugck C; Agewall S
Editorial comment: INTERNATIONAL ANGIOLOGY. 2013;32(6):608-612

Requirements for angiology/vascular medicine.

Catalano M; Poredos P; Brodmann M; Wautrecht JC; Carpentier P; Roztocil K; Nikol S; Diamantopoulos E; Pecsvarady Z; Carlizza A; Sieron A; Stanek A; Olinic D; Stvrtinova V; Kozak M; Agewall S; Gallino A; Jaeger KA; Fitzgerald P; Colgan MP
Review: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;167(5):1772-1782

Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.

Zannad F; Stough WG; Regnault V; Gheorghiade M; Deliargyris E; Gibson CM; Agewall S; Berkowitz SD; Burton P; Calvo G; Goldstein S; Verheugt FWA; Koglin J; O'Connor CM
Letter: HEART. 2013;99(13):969

Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity—the response.

Hisdal J; Agewall S; Omland T
Letter: ANGIOLOGY. 2013;64(3):245-246

Thyroid dysfunction in patients with myocardial infarction with normal coronary arteries.

Agewall S; Tornvall P
Conference publication: EUROPEAN HEART JOURNAL. 2013;34:997-998

Presence of eNOS TT genotype is associated with a poor prognosis in patients with a previous myocardial infarction

Agewall S; Henareh L; Norman B
Editorial comment: ATHEROSCLEROSIS. 2012;224(2):324-325

Non-alcoholic fatty liver disease and cardiovascular disease.

Santos RD; Agewall S
Editorial comment: ATHEROSCLEROSIS. 2012;224(2):320-321

Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat?

Griffin BA; Agewall S
Review: ATHEROSCLEROSIS. 2012;224(1):12-24

Ultrasound and radiology surrogate endpoints in pharmacological studies.

Agewall S; DeGroot E; Marcos-Alberca P; Zamorano JL; Barrero AA; Badano LP; Perrone-Filardi P
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2012;157(1):128-129

Low self-estimated quality of life after myocardial infarction and future cardiovascular risk.

Agewall S; Henareh L
Letter: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2012;41(3):240-242

Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients.

Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
Editorial comment: ATHEROSCLEROSIS. 2012;220(2):319-320

Early arterial abnormalities in young adulthood.

Rubba P; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:184-185

Myocardial infarction with normal coronary arteries is common and associated with normal findings on CMR - results from the Stockholm Myocardial Infarction with Normal Coronaries (SMINC) Study

Collste O; Sorensson P; Frick M; Agewall S; Daniel M; Jernberg T; Hofman-Bang C; Malmqvist K; Arheden H; Tornvall P
Conference publication: EUROPEAN HEART JOURNAL. 2012;33:1057-1058

Low self-estimated quality of life after myocardial infarction and future cardiovascular risk

Agewall S; Henareh L
Review: REVISTA ESPANOLA DE CARDIOLOGIA. 2011;64(12):1168.e1-1168.e60

[ESC/EAS Guidelines for the management of dyslipidaemias].

Reiner Ž; Catapano AL; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegría E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs RH; Kjekshus JK; Perrone Filardi P; Riccardi G; Storey RF; David W; Clinical Practice Guidelines Committee of the Span
Review: ATHEROSCLEROSIS. 2011;219(1):10-14

Myocardial infarction with angiographically normal coronary arteries.

Agewall S; Eurenius L; Hofman-Bang C; Malmqvist K; Frick M; Jernberg T; Tornvall P
Review: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2011;25(5):564-571

Oral antiplatelet agents in ACS: from pharmacology to clinical differences.

Agewall S; Badimon L; Drouet L; Eschenhagen T; Husted S; Simon T; Steg G
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;151(3):375-376

Troponin rise in healthy subjects during exercise test.

Tjora S; Gjestland H; Mordal S; Agewall S
Corrigendum: ATHEROSCLEROSIS. 2011;217 Suppl 1:S1-44

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Task Force for the management of dyslipidaemias of; Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Perrone Filardi P; Riccardi G; Storey RF; Wood D; ESC Committee for Practice Guidelines 2008-2010 an
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;150(1):108-111

The large clinical statin trials.

Agewall S
Review: ATHEROSCLEROSIS. 2011;217(1):3-46

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Catapano AL; Reiner Z; De Backer G; Graham I; Taskinen M-R; Wiklund O; Agewall S; Alegria E; Chapman MJ; Durrington P; Erdine S; Halcox J; Hobbs R; Kjekshus J; Filardi PP; Riccardi G; Storey RF; Wood D; European Society of Cardiology (ESC); European Atherosclerosis Society (EAS)
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2011;57(14):E1080

EXCELLENT EARLY RISK STRATIFICATION USING TROPONINS AND N-TERMNIAL PRO-BRAIN NATRIURETIC PEPTIDES IN CHEST PAIN PATIENTS BUT NO ADDITIONAL VALUE OF HIGH-SENSITIVE TROPONIN T

Melki D; Lind S; Agewall S; Jernberg T
Editorial comment: ATHEROSCLEROSIS. 2011;215(1):32-33

Ivabradine: an hypothesis generating study--an important link between bench and bedside.

Wellnhofer E; Agewall S
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2011;147(1):139-140

Sweet dreams might be bad.

Agewall S; Nesvold A
Review: EUROPEAN HEART JOURNAL. 2011;32(4):404-411

Troponin elevation in coronary vs. non-coronary disease.

Agewall S; Giannitsis E; Jernberg T; Katus H
Conference publication: EUROPEAN HEART JOURNAL. 2011;32:323

Prevention of peptic ulcers with once-daily esomeprazole 20 mg and 40 mg in low-dose acetylsalicylic acid users at gastrointestinal risk: outcome analysis by cardiovascular risk (OBERON)

Scheiman J; Agewall S; Svedberg L-E; Naucler E; Nagy P
Editorial comment: ATHEROSCLEROSIS. 2010;210(2):366

Never too late: a commentary on "Impact of age, sex and exercise on brachial and popliteal artery remodelling in humans".

Barth J; Agewall S
Meeting abstract: JOURNAL OF HYPERTENSION. 2010;28:e165

EARLY PREDICTORS OF CARDIOVASCULAR DISEASE (CVD) RISK: A 15-YEAR FOLLOW-UP STUDY OF 108 PATIENTS WITH RHEUMATOID ARTHRITIS (RA)

Provan S; Angel K; Semb AG; Agewall S; Atar D; Kvien TK
Review: PROGRESS IN CARDIOVASCULAR DISEASES. 2010;52(5):410-428

Matrix metalloproteinases in atherothrombosis.

Bäck M; Ketelhuth DFJ; Agewall S
Review: EUROPEAN JOURNAL OF ANAESTHESIOLOGY. 2010;27(2):92-137

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).

Poldermans D; Bax JJ; Boersma E; De Hert S; Eeckhout E; Fowkes G; Gorenek B; Hennerici MG; Iung B; Kelm M; Kjeldsen KP; Kristensen SD; Lopez-Sendon J; Pelosi P; Philippe F; Pierard L; Ponikowski P; Schmid J-P; Sellevold OF; Sicari R; Van den Berghe G; Vermassen F; Hoeks SE; Vanhorebeek I; Vahanian A; Auricchio A; Bax JJ; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearn P; McDonag T; McGregor K; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas P; Widimsky P; De Caterina R; Agewall S; Al Attar N; Andreotti F; Anker SD; Baron-Esquivias G; Berkenboom G; Chapoutot L; Cifkova R; Faggiano P; Gibbs S; Hansen HS; Iserin L; Israel CW; Kornowski R; Eizagaechevarria NM; Pepi M; Piepoli M; Priebe HJ; Scherer M; Stepinska J; Taggart D; Tubaro M; Task Force for Preoperative Cardiac Risk Assessmen; European Society of Anaesthesiology (ESA)
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:847

Beta blockers, statins and recommended doses of ACE-I improve survival in non-randomized patients with heart failure. A propensity score analysis of the Norwegian Heart Failure Registry

De Blois J; Fagerland MW; Grundtvig M; Gullestad L; Westheim A; Hole T; Atar D; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:674

Esomeprazole 20 mg and 40 mg for 26 weeks reduces the frequency of upper GI symptoms in patients taking low-dose acetylsalicylic acid (ASA) for cardiovascular prevention: the OBERON trial

Scheiman J; Herlitz J; Agewall S; Lanas A; Van Zanten SV; Naucler E; Svedberg L-E
Conference publication: EUROPEAN HEART JOURNAL. 2010;31:375

Peptic ulcer prevention by esomeprazole 20 mg and 40 mg once daily in patients taking low-dose acetylsalicylic acid for secondary cardiovascular prevention

Scheiman J; Herlitz J; Agewall S; Lanas A; Van Zanten SV; Naucler E; Svedberg L-E
Editorial comment: REVISTA PORTUGUESA DE CARDIOLOGIA. 2010;29(7-8):1273

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Swedberg K; Komajda M; Boehm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L
Review: EUROPEAN HEART JOURNAL. 2009;30(22):2769-2812

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.

Task Force for Preoperative Cardiac Risk Assessmen; European Society of Cardiology (ESC); Poldermans D; Bax JJ; Boersma E; De Hert S; Eeckhout E; Fowkes G; Gorenek B; Hennerici MG; Iung B; Kelm M; Kjeldsen KP; Kristensen SD; Lopez-Sendon J; Pelosi P; Philippe F; Pierard L; Ponikowski P; Schmid J-P; Sellevold OFM; Sicari R; Van den Berghe G; Vermassen F
Letter: FUNDAMENTAL & CLINICAL PHARMACOLOGY. 2009;23(2):261-262

Interpreting clinical trials: the 'beautiful' case.

Agewall S; Atar D
Review: ATHEROSCLEROSIS. 2009;202(2):330-344

Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease.

Luksha L; Agewall S; Kublickiene K
Conference publication: EUROPEAN HEART JOURNAL. 2009;30:876

COPD predicts mortality in CHF: the Norwegian Heart Failure Registry

De Blois J; Simard S; Atar D; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2009;30:762

Increased CRP early in the RA disease course predicts cardiovascular disease and arterial stiffness. 15-year follow-up of the EURIDISS cohort

Provan S; Angel K; Semb AG; Mowinckel P; Agewall S; Atar D; Kvien TK
Editorial comment: EUROPEAN HEART JOURNAL. 2008;29(16):1927-1929

Acute and stable coronary heart disease: different risk factors.

Agewall S
Letter: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2008;123(2):195-196

Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.

Saha S; Berglund M; Sylvén C; Gordon A; Agewall S
Conference publication: EUROPEAN HEART JOURNAL. 2008;29:183

Gender differences in Norwegian patients with heart failure

Agewall S; Brandsaeter B; Atar D
Review: LAKARTIDNINGEN. 2007;104(37):2586-2588

[Myocardial infarction with normal coronary arteries in women. MINCA--a specific type of myocardial infarction].

Skeppholm M; Agewall S; Ljungman P; Daniel M; Eriksson M; Hofman-Bang C; Malmqvist K; Reistam U; Svane B; Tornvall P
Editorial comment: GYNECOLOGICAL ENDOCRINOLOGY. 2007;23(7):363-365

Gender issues in cardiovascular medicine.

Kublickiene K; Agewall S
Letter: EUROPEAN HEART JOURNAL. 2007;28(4):515

Levosimendan: perpetuum mobile?

Agewall S; Atar D
Conference publication: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(9):248A

High-risk patients benefit most from angiotensin-converting enzyme inhibition after an acute myocardial infarction

Milonas C; Jernberg T; Lindback J; Agewall S; Wallentin L; Stenestrand U
Corrigendum: HAEMOSTASIS. 2007;36(2):108

Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease (vol 35, pg 440, 2006)

Agewall S; Henareh L; Jogestrand T; Norman B
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):264

Atorvastatin normalizes endothelial function in healthy smokers

Agewall S; Hernberg A
Editorial comment: EUROPEAN HEART JOURNAL. 2006;27(2):121-122

Matrix metalloproteinases and cardiovascular disease.

Agewall S
Conference publication: CIRCULATION. 2006;114(18):700

The impact of renal dysfunction on bleeding and outcome in ST-Elevation MI: Results of the ExTRACT-TIMI25 study

Fox KA; Antman E; Montalescot G; Agewall S; McCabe C; Mohanavelu S; Morrow D; Braunwald E
Conference publication: EUROPEAN HEART JOURNAL. 2006;27:665

Atorvastatin normalizes endothelial function in healthy smokers

Agewall S; Hernberg A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):397

Influence of AMPD1 gene polymorphism on coagulation factors in patients with coronary heart disease

Agewall S; Norman B
Editorial comment: EUROPEAN HEART JOURNAL. 2005;26(7):634-636

How should we evaluate an open artery in STEMI patients?

Agewall S
Letter: LAKARTIDNINGEN. 2004;101(39):3018

[Bad taste in the mouth because of the article on snuff use].

Agewall S
Letter: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2004;19(8):819

Snus is not harmless!

Agewall S
Review: CURRENT VASCULAR PHARMACOLOGY. 2003;1(2):107-109

Is impaired flow-mediated dilatation of the brachial artery a cardiovascular risk factor?

Agewall S
Letter: LANCET. 2003;361(9369):1659

Clever idiot?

Agewall S
Letter: LAKARTIDNINGEN. 2003;100(4):250

[A clever idiot?].

Agewall S
Conference publication: CIRCULATION. 2001;104(17):476

The increased vasodilatation of the brachial artery after ischaemic handgrip exercise during forearm occlusion is nitric oxide mediated.

Agewall S; Fagerberg B; Hulthe J; Gottfridsson B; Wikstrand J
Letter: CLINICAL CHEMISTRY. 2000;46(12):2016-2017

Increases of creatine kinase MB and cardiac troponin T in serum of a patient with uterine leiomyosarcoma.

Agewall S
Letter: EUROPEAN HEART JOURNAL. 2000;21(17):1482-1483

Impact of red wine on antioxidant status in vivo.

Maxwell S; Thorpe G
Conference publication: EUROPEAN HEART JOURNAL. 2000;21:489

Multiple risk intervention trial in high risk hypertensive men

Agewall S; Fagerberg B; Berglund G; Schmidt C; Wendelhag I; Wikstrand J
Conference publication: CIRCULATION. 2000;102(18):519

Multiple risk intervention trial in high-risk hypertensive men: Comparison of ultrasound intima-media thickness and clinical outcome during six years of follow-up

Agewall S; Schmidt C; Fagerberg B; John W; Berglund G; Wendelhag I
Letter: JOURNAL OF HYPERTENSION. 1998;16(10):1555

Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men - Reply

Agewall S; Wikstrand J; Fagerberg B
Letter: JOURNAL OF HYPERTENSION. 1998;16(10):1558-1559

Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men - Reply

Agewall S; Wikstrand J; Fagerberg B
Conference publication: CIRCULATION. 1998;98(17):502

Under-estimation of LV end-systolic volume & over-estimation of LV ejection fraction with Levovist is avoided by EGG triggered Power Motion Imaging.

Doughty RN; Whalley GA; Wright S; Agewall S; Walsh HJ
Review: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 1997;22(3):171-179

Treatment with beta-blockers--the value of an even plasma concentration over 24 h.

Agewall S; Kendall M
Corrigendum: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 1997;22(4):303

Treatment with β-blockers -: the value of an even plasma concentration over 24 h (vol 22, pg 171, 1997)

Agewall S; Kendall M
Conference publication: CIRCULATION. 1997;96(8):2265

Ultrasound measurements of the carotid and femoral arteries in a randomized multiple risk factor intervention trial in treated hypertensive men at high cardiovascular risk

Agewall S; Wikstrand J; Fagerberg B
Conference publication: CIRCULATION. 1996;94(8):2669

Prothrombin fragment 1+2 is a risk factor for myocardial infarction and mortality in treated hypertensive men

Agewall S; Fagerberg B; Wikstrand J
Visa fler

Forskningsbidrag

Randomized Evaluation of Beta-blocker and ACEI/ARB Treatment in MINOCA patients (MINOCA-BAT).

Swedish Research Council

1 December 2017 - 31 December 2018
Regional network for Heart Failure Research

Southern and Eastern Norway Regional Health Authority

1 January 2016 - 31 December 2019
Cardiac magnetic resonance imaging in myocardial infarction with normal coronary arteries

Swedish Research Council

1 January 2014 - 31 December 2016
Center for Heart Failure Research; a regional research network

Southern and Eastern Norway Regional Health Authority

1 January 2013 - 31 December 2015
Novel biomarkers for improvement of diagnostic and prognostic evaluation in patients at risk for myocardial cell injury.

Southern and Eastern Norway Regional Health Authority

1 January 2013 - 31 December 2016
A structuralised sick-leave program compared to usual care sick leave management in patients after an acute myocardial infarction

Southern and Eastern Norway Regional Health Authority

1 January 2009 - 31 December 2015

Anställningar

Gästprofessor, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2024
Specialist, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2023-2023

Examina och utbildning

Docent

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI